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Abstract 
 
In this thesis we present molecular modelling studies that were implemented to investigate the 
folding, unfolding and more importantly, the misfolding of proteins. An introduction to the 
principles of protein structure and function and literature review on protein aggregation and 
prevention strategies are presented in Chapter 1. In particular, we review current literature on 
human apolipoprotein C-II (apoC-II). A general overview of molecular mechanics and an 
introduction to the fundamentals to classical Molecular Dynamics are presented in Chapter 2.  
 A substantial body of literature indicates that apoC-II is present in atherosclerosis 
plaques. It was not until recently that the peptide composed of residues 60 to 70 of the apoC-II 
protein was identified to retain its ability to form amyloid fibrils independent of the full-length 
protein. Furthermore, cyclisation strategies were employed to construct a cyclic analog of 
apoC-II(60-70) and was found to be an effective inhibitor of amyloid aggregation by apoC-
II(60-70). The structure and dynamics of the cyclised apoC-II(60-70) peptide was 
characterised and compared to solution NMR structures in Chapter 3. 
 Identifying structural features and characteristics of the cyclic peptide provided the 
framework towards elucidating the possible ways that it can inhibit fibril formation by apoC-
II(60-70). Chapter 4 describes in detail the interactions and effects that the cyclic peptide 
imposes on the amyloidogenic apoC-II(60-70) peptide. The results obtained from this study 
enable us to propose a mechanism by which the cyclic peptide inhibits the aggregation 
process. 
 Although the proposed model provides a positive outlook towards understanding how 
the cyclic peptide inhibits fibril formation by apoC-II(60-70), it is still a relatively new area of 
study. Many possible investigations using the apoC-II(60-70) and its cyclic derivative can be 
performed, and ultimately completely understanding the inhibition process remains an ongoing 
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task. Section 5 describes current ongoing projects related to the inhibition mechanism of the 
cyclic inhibitor and also possible future directions. 
 
 3
 
 
 
 
 
Chapter 1 
 
 
 
 
1.  Introduction 
 
 
1.1  Chapter overview 
 
In this chapter, a synopsis of our current knowledge on the structure and dynamics of proteins 
with particular emphasis on the phenomenon of protein aggregation is presented. A brief 
introduction to protein structure and protein folding is presented in Sections 1.2 and 1.3 
respectively. Our current knowledge of protein aggregation, self-association and prevention 
strategies are described in Section 1.4. Literature review on both experimental and theoretical 
research efforts relating to apoC-II and protein aggregation is presented in Section 1.5. Finally, 
the aims of this project are described in Section 1.6. 
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1.2  Protein structure 
 
Proteins are essential biological macromolecules composed of carbon, nitrogen, oxygen, 
sulphur and hydrogen atoms. They are a vital component of all living organisms and play a 
vast number of roles, such as controlling growth and repair of living tissues, directing the 
transport and storage of small molecules and regulating metabolic pathways. Some important 
types of proteins include antibodies, hormones and enzymes. Antibodies are responsible for 
identification and neutralisation of foreign objects such as bacteria and viruses. For example, 
bapineuzumab is an antibody which has been indicated to possess potential therapeutic 
treatments of Alzheimer’s disease [1]. Hormones are “chemical messengers” responsible for 
inter-cellular signalling. Human growth hormone (HGH) is responsible for stimulating growth, 
cell reproduction and regeneration in humans. Enzymes are proteins that catalyse chemical 
reactions. For example, urease is an enzyme which catalyses the hydrolysis of urea into carbon 
dioxide and ammonia.  
There are twenty naturally occurring amino acids in proteins. The basic structure of an 
amino acid consists of a central carbon atom (Cα) with a hydrogen atom (H), an amino group 
(H2N) and a carboxyl group (COOH) attached to its first, second and third valence, 
respectively. The fourth valence of the central carbon has a unique side-chain (R) attached to it 
as shown in Figure 1.1. The side-chains determine the property of each amino acid, which can 
be classified into three classes. The first class is composed of strictly hydrophobic side-chains: 
Ala (A), Val (V), Leu (L), Ile (I), Phe (F), Pro (P), and Met (M). The second class is composed 
of charged side-chains: Asp (D), Glu (E), Lys (K), and Arg (R). Finally, the third class is 
composed of polar side-chains: Ser (S), Thr (T), Cys (C), Asn (N), Gln (Q), His (H), Tyr (Y), 
and Trp (W). Protein structures are typically described at four levels. The terms primary, 
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secondary, tertiary and quaternary structures were first adopted by Kaj Linderstrøm Lang in 
1951 in his medical lectures at Stanford University [2].  
 
 
Figure 1.1 – The general structure of an amino acid.  
  
1.2.1 Primary structure 
A protein is a polymer consisting of a long chain of amino acid residues linked together by 
peptide bonds. The primary structure of a protein is the specification of its amino acid 
sequence, which is the fundamental building blocks that uniquely define a protein, encoded 
within deoxyribonucleic acid (DNA). The primary structure of a protein is held together by 
polypeptide covalent bonds. 
Amino acids can join through protein synthesis to form polypeptide chains. This occurs 
when the OH from the carboxyl group from one amino acid (n) condenses with the H atom 
from the amino group of another amino acid (n+1). The two amino acids join together through 
the C atom of the carboxyl group (n) with the N atom of the amino group (n+1) forming a 
peptide bond. A schematic showing the peptide bond formation mechanism is shown in Figure 
1.2. 
 
H 
C N Cα 
R 
O 
O 
H 
H 
H 
 6
 
Figure 1.2 – The condensation of three amino acids. The peptides form a peptide bond (C-N), releasing a water 
(H2O) molecule between each peptide. 
 
Cysteine residues have a unique ability to form a covalent bond with another cysteine 
side chain (disulfide bond) through oxidation. The covalent bonding of the two cysteine amino 
acids is extremely strong in comparison to ionic or hydrophobic interactions, and is essential 
to the proper folding, structure and function of proteins that possess disulfide-forming cysteine 
residues. 
 
1.2.2 Secondary structure 
The protein backbone is composed of 3 repeating atoms (-N-Cα-C-) after a peptide bond has 
formed. There are three important torsion angles that govern the conformation of the protein 
backbone: φ, ψ, and ω. The φ angle is the rotation about the N-Cα bond (angle subtended by 
the two planes formed by C-N-Cα-C). The ψ angle is the rotation about the Cα-C bond (angle 
subtended by the two planes formed by N-Cα-C-N) and the ω angle is the rotation about the C-
N bond (angle subtended by the two planes formed by Cα-C-N-Cα). A schematic of the 
torsion angles is shown in Figure 1.3. 
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In most situations, the peptide plane is formed by ω with an angle close to 180º except 
for a select few circumstances (like cis-prolines). The major structural features of a protein, as 
identified by the secondary structure, are therefore governed by the two torsion angles φ and 
ψ. Dihedral angles in literature are commonly cited as (φ, ψ) in degrees.  
 
 
Figure 1.3 – A schematic representation of a polypeptide chain showing the protein backbone along with the three 
torsion angles. 
 
The secondary structure also refers to the ordered local structural features observed in 
proteins. These can be classified into several main categories: helices, sheets, turns and loops.  
Helices are formed when a sequence of amino acids adopts a winding spiral motif 
which is stabilised by the formation of hydrogen bonds between atoms of the protein 
backbone. Helices are typically quite strong due to the helix dipole moment created by the 
slight negativity of the carboxyl oxygen of each residue. There are three commonly observed 
types of helices.  310-helices have hydrogen bonds between residues i and (i+3) with (φ, ψ) 
dihedral angles of (-74.0, -4.0); α-helices have hydrogen bonds between residue i and (i+4) 
with (φ, ψ) dihedral angles of (-57.8, -47.0) and π-helices have hydrogen bonds between 
residues i and (i+5) with (φ, ψ) dihedral angles of (-57.1, -69.7). 
β-sheets are composed of a sequence of elongated peptide chains which are stabilised 
by the formation of hydrogen bonds between backbone atoms,  perpendicular to the plane of 
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the strand. The hydrogen bonding in β-sheets is weaker than the hydrogen bonds in helices, 
but play an important role; for example in stabilising protein aggregation when hydrophobic 
contacts have been initiated [3, 4]. 
Turns and loops enable a protein to adopt a wider range of conformations which can be 
often related to protein activity. These structural motifs also allow the protein to fold into 
compact tertiary structures which minimise solvent accessible surface area. 
Secondary structures are usually formed when the consecutive residues in a protein 
sequence have certain similar (φ, ψ) values as determined by the Ramachandran map [5]. The 
Ramachandran map provides a way to classify the protein secondary structure based on its 
dihedral angles which in general terms, consists of three major regions that correspond to 
structures with well-defined dihedral angles: right handed α-helix, left handed α-helix and the 
β-sheet. A typical Ramachandran map is presented in Figure 1.4. 
Steric restrictions of the amino acid side chains in a protein do not permit certain (φ, ψ) 
angles, as observed by interpretation of the Ramachandran map. However, there is one 
exception and that is the amino acid Glycine (Gly). Glycine has one hydrogen atom as its side 
chain (R), which removes the steric restrictions that other amino acids exhibit. This provides 
Gly with a higher degree of freedom and this residue is commonly associated with turns in a 
protein’s secondary structure. The increase in flexibility also allows Gly to act as a helix 
breaker which enables the protein to adopt more biologically active conformations as part of 
normal protein dynamical behaviour. 
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Figure 1.4 – Ramachandran map of the three sterically permissible regions for common secondary structures of a 
protein. The darker regions represent a higher probability for the annotated secondary structures. 
 
1.2.3 Tertiary and quaternary structure 
The tertiary structure refers to the protein’s three dimensional conformation in space. The 
formation of the tertiary structure is known to be driven by hydrophobic interactions between 
the secondary structural elements to minimise hydrophobic surfaces accessible to water [6] 
and to stabilise the protein shape [7]. A quaternary structure is formed when proteins behave in 
a collective manner. An example would be the insulin dimer which consists of two distinct 
monomer structures linked by a disulfide bond which further combine into a hexamer in the 
presence of metal ions like zinc [8]. A schematic representation of the four levels of protein 
structures is presented in Figure 1.5. 
β-sheet 
Right handed α-
helix  
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       Primary structure         Secondary structure 
      
 
Tertiary structure 
 
 
Quaternary structure 
 
Figure 1.5 - A structural representation of the primary, secondary, tertiary and quaternary structure of a protein. 
Colours are arbitrarily assigned to illustrate the sections of different secondary structure elements. 
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1.3  Protein folding 
 
Proteins fold into structures which are required for their biological function. It was 
hypothesised that the native state of a protein is the thermodynamically stable conformation 
which only depends on the information encoded in its amino acid sequence and not on its 
kinetic folding route [9]. This indirectly suggests that the formation of the native state is 
achieved by randomly sampling the conformational space available to that protein until it 
reaches its native conformation. The number of conceivable paths for a small sized protein of 
100 residues to sample has been calculated to be of the order of 1030 and possibly larger [10] 
before finding its native state, which would require many decades to achieve. However it has 
been established that proteins fold within a timeframe of microseconds to seconds. This 
phenomenon has been coined as Levinthal’s paradox [11].  
The existence of a folding pathway enabling a protein to fold within a realistic 
timeframe was suggested in 1969 [11]. This proposition therefore not only satisfies the time 
constraint, but also assumes the possibility of a kinetic control to the folding process. In 
essence, this model suggests the existence of an intermediate state (I) in relation to the 
unfolded state (U) to be crucial before a protein can reach its native state (N); however a 
problem with the on-pathway model is that it implies the existence of only one route for a 
protein to fold whereas the off-pathway implies that off-pathway intermediates are 
independent of the actual folding process [12] (see Figure 1.6).  
 
                               
 
Figure 1.6 – A schematic representation of the on-pathway (left) and off-pathway (right) model. In the on-
pathway model, intermediate states are located en-route of the native state; however, the off-pathway suggests 
that the native state has no dependency on intermediate states. 
U I N 
U 
I 
N 
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It soon became evident that there are many pathways through which a protein could 
fold, each with their own transition states [13]. The folding funnel model [14] hypothesises 
that for a protein, all pathways lie on a funnelled energy landscape which enables a protein to 
fold to its native state through a stochastic process where the free energy decreases rapidly. 
The model suggests that the protein begins from a region of high energy which progressively 
travels down the funnel landscape upon which the protein becomes “trapped” in a region of 
minimum energy. It has been shown that despite the existence of a higher statistical preference 
towards a specific pathway [15], off-pathway intermediates could appear in a number of 
pathways which lead to the native state [16]. It has been shown previously that the energy 
landscape of a protein is rugged in nature, exhibiting local minima and saddle point features 
[17]. The implications of a rugged energy landscape suggest the existence of various folding 
pathways, which may lead to different local minima or regions of identical minimum energy. 
In some instances, the protein may spend some time trapped in these minima before 
continuing down the funnelled landscape. The funnelled energy landscape model has been 
verified by NMR experiments, revealing a series of transition states with compact 
conformations [18]. 
There have been advancements in both experimental techniques and computational 
approaches that have provided additional insight in the protein folding mechanisms. 
Experimental techniques such as nuclear magnetic resonance (NMR), mass spectrometry and 
atomic force microscope (AFM) are now able to provide detailed information on 
conformational changes that occur during the folding process [19]. Computational approaches 
have also made quite a journey since the infancy stage dating back to the use of energy 
minimisation techniques [20], which was shortly followed by the application of molecular 
dynamics (MD) [21]. Since then, novel computational approaches such as bias exchange 
metadynamics [22], replica exchange molecular dynamics [23-25], and multiplexed-replica 
exchange molecular dynamics [25] have been employed successfully to further the 
 13 
understanding of the folding dynamics of peptides. Developments in the computational field 
has advanced so far that it is now possible to utilise high performance computing facilities 
from around the world through a worldwide computing network known as Folding@Home 
[26].  
Computational modelling has continued to contribute to the elucidation of the complex 
phenomenon of protein folding. In particular, classical atomistic molecular dynamics 
simulations has also been able to complement experiments by providing atomistic details that 
traditional experimental techniques still cannot achieve. However, theoretical prediction of the 
folding pathways of a linear polypeptide strand remains a challenge.  
 
1.3.1 Protein unfolding and denaturation 
Studying the dynamic and structural properties of denatured proteins present key concepts in 
the elucidation of protein folding and misfolding events [27, 28]. An example is the 
thermodynamic stability of a protein, which requires accurate approximations of the denatured 
state as a reference state. Understanding the structural properties of unfolded proteins will 
subsequently provide insight into the early events of protein folding and aggregation [29].  
Studies have shown that denatured states of proteins consist of featureless random-coil 
like conformations with the possibility of retaining residual native-like structures [30-32]. 
Conformational bias of native structures in the denatured state has been observed in various 
studies, providing possible explanation to Levinthal’s paradox [33-35]. Formation of a random 
coil that retains residual native secondary structures is suggested to be a rate limiting process 
of the packing of preformed secondary structures into its correct fold [36]. In contrast, a 
random coil model that does not retain residual native secondary structures implies that the 
protein has to overcome a high entropic barrier upon folding to form its secondary and tertiary 
structure.  
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Despite the significant recent progress made in regards to protein folding, unfolding 
and misfolding, our current knowledge remains limited. It is evident that further research into 
the ambiguities of the process and pathways of protein folding is required. 
 
1.4  Protein aggregation and self-association 
 
The information required for a protein to fold in to its physiological functioning state is 
encoded in its amino acid sequence. However, other external factors have an impact on its 
folding ability. In a cellular environment surrounded by various proteins, a polypeptide is 
required to search for its correct folded state in order to perform its function. Proteins that are 
trapped in meta-stable intermediates are usually recognised by chaperones and are degraded or 
refolded. However, misfolded proteins may also exist, which can self-associate and form 
either amorphous compounds or well-ordered structures of elongated-unbranched morphology. 
These latter aggregates are called amyloid fibrils. An accumulation of amyloid fibrils may lead 
to a range of neurodegenerative diseases commonly referred to as amyloidosis. Diseases 
associated with amyloid fibrils are Parkinson’s, Alzheimer’s, variant Creutzfeldt-Jakob, type II 
diabetes and other prion related diseases [37-39]. 
 
1.4.1 History of amyloids 
The term “amyloid” first appeared in a publication made by Rudolf Virchow in 1854, used to 
describe structural deposits discovered in human tissue [40]. The initial staining method was 
introduced by Virchow to identify amyloid [41, 42], consisting of a water solution composed 
of iodine and hydrated sulfuric acid [43]. Amyloids were originally thought to be cellulose in 
nature due to the staining effect being reminiscent of the starch-iodine reaction [44, 45]. 
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However, in 1959 Friedreich and Kekulé dissected an amyloid-rich segment of a human spleen 
and found upon direct chemical analysis that the main constituent of amyloids is protein [46]. 
Iodine staining was later replaced by Congo red, a dye that has been used as a cotton 
colourant in the textile industry since 1884. Congo red was discovered to exhibit a strong 
affinity for amyloid deposits, producing enhanced double refraction patterns (birefringence) 
after interaction with amyloids [47]. Other staining methods such as Thioflavin T (ThT) and S 
(ThS) are also amongst the more frequent staining methods used today. 
 
1.4.2 Structure of amyloid fibrils 
An early X-ray diffraction (XRD) experiment involving poached egg whites suggested the egg 
whites pack in an extended β-conformation, with chains perpendicular to the long axis (fibril 
axis) [48]. Experimental studies involving light microscopy and electron microscopy reached 
the same conclusion in regards to the structure of amyloids [49-51]. Recent technological 
advances provided scientists with tools to re-examine the fibril architecture in atomistic detail 
[52-55]. The studies have provided insight into the specific structural organisation of amyloid 
fibrils and show that despite the fact that many proteins of unrelated sequence can form 
amyloid fibrils, the morphology of the fibrils is similar, and contain a cross-β structure with β-
strands perpendicular to the fibril axis. A fibril model of human Islet Amyloid Polypeptide(20-
27) is shown in figure 1.7. 
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Figure 1.7 – Structural representation of the fibril model of hIAPP(20-27) (PDB code: 2KIB). 
 
1.4.3 Fibril formation – models and mechanisms 
The process of protein fibrillisation is complex and not well understood. However, there are 
some proposed mechanisms and models that may help in the elucidation of fibril formation. 
Selected models are described below, although no single model currently accounts adequately 
for all observable properties of fibrils [56]. 
In the nucleation model of amyloid fibril formation, the nuclei form during a lag phase 
which is rapidly followed by association between oligomers. When pre-formed fibrillar 
species are introduced into a sample of protein under aggregation conditions, the lag phase is 
significantly reduced. This phenomenon is known as “seeding”. After the nuclei are formed, it 
is believed that the rate of aggregation is no longer dependent on nucleation [57]. 
In the refolding model, fibril-forming proteins undergo unfolding and refolding. 
Fibrillar states of proteins are observed to share common morphologies and diffraction 
patterns that are independent of the sequence of the protein, suggesting that the fibrillar state is 
defined by backbone hydrogen bonds [58]. The specific amino sequence is not an important 
factor in the refolding model, however it has been shown that the amino acid composition can 
affect the stability of the fibrillar state and its rate of fibrillisation [59]. 
Fibril Axis 
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The cross-β spine model describes the conformational change in regions of the protein, 
exposing previously inaccessible surfaces. The exposed segments of the protein chain have a 
propensity to interact and stack into a β-sheet. The native structure of the protein is usually 
retained in the fibril with the exception of the interaction surface and its links to the core 
domain.  
 
1.4.4 Aggregation studies 
Non-fibrillar intermediates such as those of amyloid β-peptides (Aβ) have been shown to 
exhibit cytotoxicity in Alzheimer’s disease [60], indicating a need in understanding the 
structure and dynamics of non- and pre-fibrillar oligomers. In particular, cognitive impairment 
in Alzheimer’s disease has been associated with low molecular weight oligomers of Aβ [61]. 
The specific conformational features and interactions that influence the stability and formation 
of the low molecular weight oligomers therefore are of great interest. However, the diverse 
morphology and rapid conformation fluctuations of the oligomers render experimental 
characterisation difficult [4], which supports studies by computational techniques [53, 61-63]. 
Proteins and peptides such as Aβ and prion proteins that can convert from α-helical to 
β-sheet conformation and form amyloid fibrils, contain an α-helix that is composed of residues 
that strongly favour β-strand formation. A study [64] revealed that the addition of tripeptide 
KAD or phospho-L-serine with Aβ resulted in an increase in α-helical content of Aβ(12–28) 
which reduced aggregation and fibril formation of Aβ(1–40), Aβ(12–28), Aβ(12–24), and 
Aβ(14–23). In contrast, tripeptides with all-neutral, all-acidic or all-basic side chains had no 
significant effects on the secondary structure or fibril formation of Aβ. It was suggested that 
the discordant α-helix found in “free” Aβ lacks stabilising interactions and that reduction of 
fibril formation could be possible if the discordant α-helix is stabilised. 
Simulation studies [53] revealed the Aβ(16-22) peptide to be the most stable in an anti-
parallel β-sheet orientation. Solvent exposure of a hydrophobic region is currently believed to 
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be an important factor in fibril aggregation by Aβ (10-35) [65]. The dimerisation propensity of 
the Aβ(10-35) peptide was also investigated as dimerisation is thought to be the first step in 
aggregate formation. The structure of Aβ(10-35) peptide dimer was shown to be stable when 
desolvation of the hydrophobic residues occurred at the interface [66]. Additionally, the 
flexibility of the C terminus of Aβ(42) was investigated and suggested to be responsible for 
the higher propensity of this peptide to form amyloid fibrils [67]. 
Insulin has also been found to undergo fibril formation and is associated with 
pathological conditions such as Diabetes Mellitus [68]. The aggregation of insulin has been 
explored through experimental techniques including atomic force microscopy [69], infrared 
spectroscopy [70] and mass spectroscopy [71]. The conditions of these studies are often 
intended to correspond to the logistics and handling of pharmaceutical insulin, typically 
involving low pH and high temperatures. Fibrils formed in these conditions are believed to 
involve the nucleation of partially unfolded monomers to form protofibrils. These protofibrils 
may then intertwine to form fibrils or undergo elongation and lateral growth by the addition of 
non-native monomers, leading to large insoluble aggregates associated with insulin 
amyloidosis [71-74]. 
Acylphosphatase can be converted into amyloid fibrils by addition of trifluoroethanol 
(TFE), with structures similar to those observed in a range of debilitating neurodegenerative 
diseases [75]. Its fibril forming propensities were investigated via a series of mutants of 
acylphosphatase by monitoring the range of TFE concentrations that resulted in aggregation. It 
was found that the tendency to aggregate correlates inversely with the conformational stability 
of the native state of the protein in the different mutants. The most strongly destabilised 
acylphosphatase variants formed fibrils in aqueous solution in the absence of TFE. This study 
revealed that the aggregation process which leads to amyloid deposition initiates from an 
ensemble of denatured conformations, with conditions that favour non-covalent interactions. 
Subsequently, this led to the hypothesis that the stability of the native state of globular proteins 
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is a major contributing factor which prevents in vivo conversion of natural proteins into 
amyloid fibrils under non-pathological conditions. This suggests that amyloidogenic diseases 
may be prevented through stabilisation of the native states of amyloidogenic proteins. 
 
1.4.5 Amyloid prevention studies 
Numerous studies involving novel ways to prevent amyloid fibril formation have been 
performed in the past. Strategies to prevent, reverse or inhibit protein aggregation involve 
specific residue mutations [76-85], site-specific addition or subtraction of charge [86], altering 
the sequence specificity of an amyloidogenic peptide [87, 88], reducing inter-peptide 
hydrophobic interactions [79, 89-92] and the use of cyclic peptides as a framework for the 
development of fibril inhibitors (discussed in section 1.4.6). Some examples of these studies 
are reviewed here. 
The prevention of amyloid fibril formation of amyloidogenic chicken cystatin has been 
demonstrated through site-specific glycosylation [77]. Chicken cystatin C (cC) has been 
identified to share a 62.5% structural similarity with human cystatin C (hcC) [93]; a protein 
known for its propensity to form fibrils in human blood vessels, which leads to frequent 
hemorrhagic stroke [94]. The study suggested that N-linked glycosylation through site-
directed mutagenesis could prevent amyloid fibril formation of cC without affecting its 
inhibitory activities at position 106 (Asn). Another study that investigated the prevention of 
amyloid fibrils by cystatin C involved substitution of Leu68Gln with disulfide bridges [76]. It 
was observed that all variants engineered with disulfide bridges were resistant towards 
dimerisation and the capacity of the disulfide variants of the wild type cC to form amyloid 
fibrils was reduced by 80% compared to its wild type counterpart. 
The prevention of amyloid formation by α-synuclein using modified-pyrroloquinoline 
quinone (PQQ) has been demonstrated in a recent study [95]. PQQ is a cofactor in bacterial 
oxidative metabolism of alcohols and is approved by FDA as a novel food additive. It was 
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shown that specific interactions between whole α-synuclein and modified-PQQ lead to the 
prevention of amyloid formation. Thus, PQQ could be employed as a target specific amyloid 
formation inhibitor with the possibility to confer specificity to small molecule inhibitors. 
Similarly, the prevention of fibril aggregation by α-synuclein using a molecular chaperone, α-
crystallin has been demonstrated [96]. It was shown that the efficiency with which α-crystallin 
suppresses fibril formation depended on temperature. α-crystallin chain B was observed to 
interrupt α-synuclein aggregation at its earliest stages, most likely by binding to partially 
folded monomers, preventing their aggregation into fibrillar structures. 
There have been increasing amounts of studies that employ computer simulations to 
provide insights into the characteristics of amyloid aggregates [87, 97-99] as computational 
techniques become more efficient. Some recent examples are given below. 
A study [79] examined through MD simulations, the effects of mutating the 
polymorphic amyloid NNQNTF segment of Elk Prion, which is known to form amyloid 
fibrils. The study showed an increase in oligomer stability in the presence of β-strands, which 
were stabilised by hydrophobic interactions. This suggests the disruption of hydrophobic 
interactions may result in a reduction in oligomer stability. Additionally, non-polar effects 
were observed in wild type and mutant NNQNTF oligomers, reinforcing the hypothesis of 
hydrophobic interactions as the principal driving force in fibril formation by Elk Prion. 
Similar mechanisms were observed in a MD simulation study of well-ordered octamers 
of an amyloidogenic hexapeptide NFGAIL of the human islet amyloid polypeptide [91]. The 
study revealed that the main growth mode was an elongation along the β-sheet hydrogen 
bonds, which occurred in a two-stage process. The two-stage process was found to be 
primarily driven by hydrophobic forces, where the peptide initially attached to the surface of 
the ordered oligomer and rapidly shifted to the β-sheet edges, which formed stable β-sheet 
hydrogen bonds. The observations from this study also suggest disruption of the hydrophobic 
interactions as a key element in the prevention of fibril formation. 
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The contributions of different structural elements of trimeric and pentameric full length 
Aβ(1-42) aggregates were studied using MD [92]. The study revealed compact packing of 
side-chains that surround the β-sheets inherent in the Aβ(1-42) aggregate. Interestingly, 
Aβ(31-42) was observed to tightly organise into a β-helix, with significantly less structured 
packing in the remaining residues. The hydrophobic core comprising the Aβ(31-42) residues 
were found to be a crucial stabilising element in the Aβ aggregation process. The results 
suggest that targeting the packing of the side-chains and the local hydrophobic core may be a 
potential strategy in preventing aggregation. 
For further reading, a concise review of the current amyloid prevention strategies have 
been summarised in [100]. See references within.  
 
1.4.5 Peptide cyclisation 
Cyclic peptides (CP) consist of peptides where a bond is formed between two residues in the 
native sequence, creating a closed-loop conformation. CPs can be classified into two general 
categories; homodetic, in which true peptide bonds exist throughout the peptide; and 
heterodetic, in which a mixture of peptide bonds and other types such as cysteine linkages 
serve to form a closed-loop. CPs inherently possess increased chemical, enzymatic and 
metabolic stability, better receptor selectivity and increased activity profiles [101, 102]. CPs 
are metabolised at a slower rate due to their resistance towards chemical degradation. 
However, they are excreted more rapidly than their linear counterparts as a result of their 
hydrophobic affinity. Furthermore, many hormones, antibiotics and toxins such as 
cyclosporine, bacitracin and α-amanitin, exist naturally as CPs [103].  
An interesting property of cyclic peptides is their extreme resistance to digestion. This 
trait enables CPs to remain intact in the human digestive tract and has attracted attention in the 
protein-based drug design industry [104]. CPs can, in theory be utilised as carriers i.e. an 
engineered scaffold that incorporates arbitrary protein domains for therapeutic agents that 
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allow for oral delivery. Studies on the structure of CPs may therefore, enable potential 
therapeutic treatments of various pathological conditions, including Alzheimer’s [100, 105, 
106].  
A study was recently conducted using backbone cyclic peptides as inhibitors of protein 
kinase B (PKB/Akt) [107], which is commonly associated with various types of cancers. The 
results from this study indicate that the backbone-to-backbone cyclisation of urea had a 
significant increase in PKB/Akt inhibition compared to N-terminus-to-backbone cyclisation. 
Both arrangements were found to have increased activity in comparison to their linear 
counterparts, suggesting that the cyclisation of urea may be a positive direction towards the 
inhibition of PKB/Akt. In addition, recent studies revealed that cyclic peptides confer protease 
inhibition activity [108] and reduce α-synuclein toxicity [109]. Similarly, the cyclisation of 
Aβ(1-28) at residues 17 and 21 via a lactam bridge has been shown to inhibit fibril formation 
by Aβ(1-40) and reduce its cytotoxicity [110]. These studies indicate that cyclic peptides have 
a potential therapeutic capability which aid in the treatment of pathological disorders.  
MD simulations and animal studies were performed to study cyclic and linear peptides 
that contain the Asn-Gly-Arg (NGR) motif [111]. The NGR motif has been proven useful for 
the delivering of anti-tumour compounds and viral particles to tumour vessels [112-114]. The 
role of cyclic constraints on the structure of NGR peptides containing cyclic (CNGRC-TNF) 
and linear (GNGRG-TNF) NGR domains were studied. Results from animal models show that 
both the CNGRC and GNGRC peptide moieties can target tumours. However, the anti-tumour 
activity of CNGRC was ten-fold greater than the GNGRG. The MD simulations from this 
study suggest that the NGR motif has a strong propensity to form β-turns and suggests that the 
disulfide constraint is crucial for the stabilisation of the bent conformation, which increases the 
tumour targeting efficiency. 
The insertion of cyclic peptide nanotube into a DMPC (dimyristoyl 
phosphatidylcholine) lipid bilayer was studied using MD [115]. The study revealed the 
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retention of the hollow tubular structure of the nanotube upon insertion into the DMPC 
bilayer. The tilt of the channel was observed to be in agreement with experimental findings 
[116, 117]. Similarly, another MD study using course grained methods to study the insertion 
of a cyclic nanotube into a DMPC lipid bilayer was performed [118]. This study also revealed 
the cyclic peptide nanotube to spontaneously insert into and reorientate inside the DMPC 
bilayer. The long axis of the nanotube was revealed to align roughly perpendicular to the 
bilayer plane. In addition, a MD simulation study was performed on the self assembly of 
cyclic D, L-α-peptides into hollow nanotubes [119]. Peptides in a dimer complex were found 
to be stable only in nonpolar solvents. Moreover, single peptide subunits prefer to reside close 
to the nonane/water interface rather than bulk water because of the amphiphilic character of 
the peptide ring. These findings suggest that cyclic peptides can function as ion channels and 
as antibacterial agents. 
MD and biophysical studies on a cyclic antimicrobial peptide BPC194 and its inactive 
linear analog, BPC193 were performed [120]. The study revealed that the BPC194 analog 
caused large perturbations in the DPPG (dipalmitoyl-phosphatidylglycerol) lipid bilayer which 
created a disordered toroidal pore of 1-2nm in diameter. Dual-color fluorescence burst analysis 
revealed BPC193 and BPC194 were able to form liposome aggregates but only BPC194 
possesses the ability to porate the bilayer. The results suggest that the cyclic peptide can adopt 
a favourable orientation towards the membrane with an ordered structure that allows a high 
charge density and amphipathic arrangement. This enables the cyclic peptide to perturb the 
membrane and form discrete pores. The high conformational entropy of BCP193, due to its 
lack of cyclisation, destabilises the formation of a folded structure and consequently its 
amphipathic characteristic, resulting in a much lower propensity to induce pores. These 
findings provide detailed insight into the mode of action of cyclic peptides and aid in the 
rational design of new antimicrobial molecules. 
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Besides the potential of being engineered and designed as a drug carrier or 
antimicrobial agent, cyclic peptides have also been found to harbour other properties with 
potential applications, including electronic and photonic devices [121]. A recent patent was 
granted where it is claimed [121] that a family of cyclic peptides comprising chromophore 
residues possess electronic and electro-optic properties. The patent indicates that cyclic 
peptide nanotube structures formed from a plurality of stacked cyclic peptides provide 
molecular scale conductivity and non-linear optical behaviour.  
Macrocyclic β-sheet peptides composed of the tau-derived peptides were studied using 
ThS Assays [122]. The tau-derived peptide Ac-VQIVYK-NH2 (AcPHF6) was found to 
aggregate in solution through β-sheet interactions to form straight and twisted filaments, 
similar to those formed by tau-protein in Alzheimer's neurofibrillary tangles. Macrocycles 
containing the pentapeptide VQIVY were found to suppress the onset of aggregation by 
AcPHF6. The results from this study led to a proposed model of aggregation, where the 
AcPHF6 amyloid grows as a layered pair of β-sheets. The growth of the β-sheets can be 
blocked by a pair of macrocycles that cap the growing paired hydrogen-bonding edges. 
In summary, cyclic peptides have been shown as a novel strategy to combat 
pathological disorders. However, there remains a lack of studies on possible effects of cyclic 
peptides on the initial stages of fibril formation. This lack of reported investigation forms a 
ground for our present investigation on how cyclic peptides can influence amyloid fibril 
formation at the atomic level, of one of the well characterised amyloidogenic proteins, apoC-
II. 
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1.5 Apolipoprotein C-II 
 
Apolipoprotein C-II (apoC-II) is a very-low-density-lipoprotein (VLDL) 79 residue protein 
synthesised in the liver and intestines. ApoC-II is secreted as a surface component of 
chylomicrons, high-density lipoproteins (HDL) and VLDL [123-125] and is involved in a vital 
physiological role as an activator of lipoprotein lipase (LPL) [126, 127]. LPL is a water 
soluble enzyme found in the capillaries that hydrolyses triglycerides in lipoproteins into 
glycerol and free fatty acids [128]. Genetic deficiency of apoC-II has been associated with 
hypertriglyceridemia [129], a condition that involves elevated blood levels of triglycerides, 
consequently linked to atherosclerosis [130].  
 
1.5.1 Structure of ApoC-II 
The structure of full length apoC-II was initially determined using NMR techniques in the 
presence of sodium dodecyl phosphate (SDS) micelles [131]. ApoC-II was found to contain 
three helical conformation regions comprised of residues 16-36, 50-56 and 63-77. However, 
shortly after, the lack of similarity between the SDS micelle and lipoprotein particles made 
interpretation of the data difficult. Subsequently, a new study involving similar NMR 
techniques with a change of surfactant from SDS micelles to dodecyl phosphocholine (DPC) 
micelles proved to be a more accurate alternative to the SDS micelle study [132]. ApoC-II in 
presence of DPC micelles was identified to contain a well-defined α-helical region at residues 
15-39 and 63-77, a disordered sequence predominated by coil and turn structures at residues 
40-65 and an unidentifiable region between residues 1-12. The structure of apoC-II is shown 
in Figure 1.8. 
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Figure 1.8 – The amyloidogenic region apoC-II(60-70) (left) in the full chain apoC-II protein (right) [132]. 
 
ApoC-II has been observed to bind reversibly to the polar lipid surface of plasma 
lipoprotein particles in vivo, associating with a variety of both natural and synthetic lipid 
surfaces in vitro. A change in secondary structure usually accompanies this process.  
ApoC-II is generally hypothesised to associate with lipid surfaces by the means of class A2 
amphipathic helices [133]. Class A2 amphipathic helices are defined as α-helices with 
hydrophobic and hydrophilic residues segregated onto opposing faces oriented along the long 
axis of the helix [134].  
 A recent study involving experimental and computational techniques was performed to 
characterise the structure of amyloid fibrils formed by apoC-II [135]. XRD results show 
apoC-II adopts a simple cross-β-structure composed of two parallel β-sheets. Transmission 
electron microscopy (TEM) and atomic force microscopy (AFM) techniques indicate the 
structure of fibrils to be flat ribbons composed of one apoC-II molecule per 4.7 Å rise of the 
cross- β-structure. MD simulations revealed apoC-II to contain a stable cross β-core with 
flexible connecting loops which are devoid of persistent secondary structure.  
.. 60   61   62    63   64    65   66   67   68    69   70 .. 
  Met Ser Thr  Tyr  Thr  Gly  Ile  Phe Thr  Asp Gln 
 27 
1.5.2 ApoC-II aggregation studies 
ApoC-II is a protein that is structurally and functionally unrelated to other proteins known to 
be prone to aggregation, although it appears to undergo the same biochemical and biophysical 
processes to form these aggregates at physiological pH without agitation. ApoC-II has been 
identified in atherosclerotic plaques in vivo [136] and is found co-localised with serum 
amyloid P (SAP) in human coronary artery plaques [137]. The fibrils formed by apoC-II in 
vitro are observed to be homogenous through electron microscopy which displays a 
characteristic XRD pattern, indicating the formation of cross-β structure [138]. ApoC-II is 
composed of mostly α-helical structures in lipid-rich conditions, however in lipid-depleted 
conditions, apoC-II aggregates into twisted ribbon-like fibrils. 
A previous study utilising analytical ultracentrifugation has shown that mature apoC-II 
fibrils assemble via a reversible pathway, incorporating fibril breaking and joining processes 
[139]. Fibril inhibition by apoC-II has been observed at micellar concentrations of 
phospholipids and fibril acceleration at sub-micellar concentrations [140-143]. Results 
identified similar structural features and properties consistent with fibril-forming propensity 
such as the formation of β-hairpin, higher solvent accessible surface area and the relative 
orientation of the aromatic rings (discussed in Sections 3.4.2.2 and 4.4.3) between Tyr63 and 
Phe67. In addition, oxidation of methionine in apoC-II  (Met9 and Met60) was shown to result 
in inhibition of fibril formation, with no effects on mature apoC-II fibrils suggesting that 
oxidised molecules have a reduced ability to interact with nascent fibrils [144]. Single residue 
mutations of Met60 with valine showed similar kinetics to native fibril formation of ApoC-II. 
In contrast, mutations of Met60 with glutamine showed significant lag phase increase times in 
the formation of fibrils [85]. A strong hydrophobic core region was observed in both of these 
mutated peptides. It can be inferred from the results that the presence of a three-residue β-turn 
(Thr-Gly-Ile) may be responsible for initiating the aggregation process. The aggregation 
process is believed to be facilitated by the availability of the backbone atoms in the β-turn 
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segment for hydrogen bonding and hydrophobic interactions with nearby molecules. These 
findings suggest that changes in the hydrophobicity of the apoC-II protein can be significant in 
the reduction of the rate of fibril formation.  
A hydrogen-deuterium exchange and proteolysis study identified residues 60-70 
(apoC-II(60-70)) and 56-76 (apoC-II(56-76)) as the core regions within the apoC-II fibrils that 
stimulate amyloid formation in solution [145]. The study showed that synthetic apoC-II(56-76) 
readily forms fibrils with different morphology and ThT yield compared to the full apoC-II 
protein and apoC-II(60-70). This observation suggests that apoC-II(60-70) may be the 
fundamental cause of apoC-II and its derivatives to form amyloid deposits in vivo. The 
amyloidogenic region within the apoC-II protein is shown in Figure 1.8. 
Experimental and computational techniques have shown that the native apoC-II(56-76) 
and Met60Gln mutated apoC-II(56-76) peptides readily assemble into fibrils with a similar lag 
phase to the fibrils formed by the native apoC-II protein [84]. In contrast, oxidised Met60 was 
observed to form fibrils with a longer lag phase. The study showed that apoC-II(56-76) 
exhibits different fibril forming kinetics compared to the full length protein, suggesting that a 
different mechanism of fibril formation is present. 
A recent study revealed distinct differences in the secondary structure of apoC-II(60-
70) in the presence of lipids and changing pH conditions [89]. In low-neutral pH conditions, 
fibrils formed readily with a propensity to adopt structures similar to a β-hairpin. The β-hairpin 
structure exhibited a strong hydrophobic core that is hypothesised to exhibit favourable 
structural features for peptide-peptide interactions. In lipid-rich conditions, a significant 
reduction of β-sheet conformations was observed. Further MD simulations were performed to 
study the effects of lipids on apoC-II(60-70) [146, 147]. The studies revealed a higher number 
of interactions occurring between the lipids and the hydrophobic residues of apoC-II(60-70). 
The lipid heads were found to interact more favourably with the hydrophilic regions of the 
apoC-II(60-70) peptide. In contrast, the lipid tails only interacted with the hydrophobic 
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regions. These results suggest a micelle-like formation where the lipid heads are solvent 
exposed, burying the lipid tails into the peptide. The favourable interaction sites were 
identified at the aromatic side chains, Tyr63 and Phe67. At low concentrations (1-3:1 
lipid:peptide ratio), the peptide adopted extended β-strand conformations caused by contacts 
with the lipids, reducing intramolecular interactions. In contrast, at high concentrations (4-
6:1), a restraining effect of lipids on the peptide’s flexibility was observed due to the lipid’s 
ability to trap the peptide in a particular conformation. A separate study involving ThT 
fluorescence showed that sub-micellar levels of short chain phospholipids of 1,2-dipentanoyl-
sn-glycero-3-phosphocholine (D5PC) and 1,2-dihexanoyl-sn-glycero-3-phosphocholine 
(D6PC) strongly inhibited fibril formation [90]. It was proposed that the trapping of 
oligomeric complexes allowed peptide-bound lipids to inhibit fibril formation, subsequently 
reducing nucleation and growth rates. These findings indicate that a lipid coating effect 
experienced by apoC-II(60-70) can directly mediate the initial interaction between the 
monomers. 
Additionally, an MD study on the oligomeric assembly stability of apoC-II(60-70) of 
various sizes and arrangements had been performed [148]. It was revealed that an increase in 
the number of strands, regardless of strand orientation, improved stability of the oligomers 
dramatically. Assemblies in an antiparallel arrangement between the strands were more 
favourable, indicated by a lower root mean square deviation (RMSD) compared to the parallel 
oligomers. The results showed that the high stability of the β-sheet structure can be attributed 
to the presence of a strong hydrophobic core between the aromatic residues, Tyr63 and Phe67. 
The presence of two aromatic residues was found to enhance the durability of the β-sheet by 
the π-stacking formation by the rings. Furthermore, the results indicate that once the fibril 
nucleus had been formed, the oligomers become stable and are unlikely to dissociate. 
Experimental results obtained through solid state NMR spectroscopy revealed that 
constraining the N- and C- termini of apoC-II(60-70) via cross-linking of cysteine residues 
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introduced at each end of the peptide inhibit fibril formation by apoC-II(60-70) [88]. This 
suggests that the cyclic peptide may serve as inhibitors of apoC-II aggregation, with potential 
therapeutic application in the treatment of atherosclerosis. This hypothesis is investigated in 
this thesis by all-atom molecular dynamics simulations. 
 
1.6  Project Aims 
 
As discussed in section 1.5.2, apoC-II(60-70) has been flagged as an initiator for fibril 
formations. ThT fluorescence studies have been able to physically show a significant reduction 
in fibril activity in apoC-II(60-70) at substoichiometric concentrations of its cyclic derivative, 
cyc(60-70). The intent of the present study is to investigate, through the application of 
molecular dynamics techniques, the mechanism behind the aggregation inhibition activity that 
cyclic apoC-II (60-70) exhibits.  The specific goals of this study are categorised below: 
 
i. Determine the most populated (stable) conformations of the cyclised apoC-II(60-70) 
peptide, cyc(60-70)  
ii. Characterise the structure and dynamics of the cyc(60-70) peptide 
iii. Determine the mode of interactions between cyclic and linear apoC-II(60-70) peptides 
iv. Suggest the mechanism responsible for fibril inhibition by cyc(60-70)  
v. Gain insights into the atomic-level mechanism of fibril inhibition, which can aid the 
design of potential cyclic peptides with optimised fibril inhibitory efficacy  
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Chapter 2 
 
 
 
 
2.  Computational modelling of proteins 
 
 
2.1  Chapter overview 
 
In this chapter, an overview of different molecular modelling methods is presented, with 
particular emphasis on molecular dynamics. In section 2.2, a breakdown of the accessible size 
and time scale for different types of simulation methods is presented. Section 2.3 presents the 
fundamentals of molecular dynamics, whilst section 2.4 discusses model construction and 
simulation set ups. Finally, techniques utilised for the analysis and interpretation of the 
simulation data are presented in section 2.5. 
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2.2  Molecular Modelling 
 
Molecular modelling is a term used to encompass all computational techniques and theoretical 
methods to model the structure, interactions and dynamics of molecules. Early efforts in 
protein modelling date back to 1953 by Corey and Pauling [149], where a scale model was 
developed from hard wood connected by steel rods and clamps. The structural data obtained 
from XRD enabled to model correct atomic proportions based on their van der Waals radii. 
The Corey-Pauling model was revised in 1960 by Koltun, which proved to be very useful for 
visualisation. Today, this model is known as the CPK (Corey-Pauling-Koltun) model. 
Simulation techniques can be classified into several categories, shown in Figure 2.1. 
Ab-initio and Density Functional Theory (DFT) methods are amongst the most accurate 
methods in molecular modelling. The energy of molecular systems is calculated from first 
principles by numerically solving the Schrödinger equation (ab-initio) or approximations of 
density (DFT). Despite the accuracy of these methods, it is unfeasible to utilise these methods 
for protein modelling due to current limitations in system sizes that can be modelled efficiently 
and accurately using today’s computers. Semi-empirical methods offer a more cost efficient 
alternative by treating the valence electrons explicitly and fitting several parameters to 
experimentally obtained data. However, these quantum mechanics (QM) methods are only 
necessary for studies involving bond breaking and formations and other electronic 
rearrangements which in most cases are not essential in protein interactions (with the notable 
exception of enzymes) [150]. The QM methods are also essential for parameterisation of 
interatomic interaction potentials. 
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Figure 2.1 – Diagram of the accessible size and time scale for different types of simulation studies. 
 
Molecular mechanics methods are based on the Born-Oppenheimer approximation and 
is typically used for larger system sizes and time scales. This approximation eliminates 
dependency on the electron motion from the Hamiltonian of the system, simplifying the 
calculations required. The remaining variables provide information on the microscopic state of 
the system from the position and velocities of the nuclei (atoms). The interaction between 
atoms are modelled using interatomic potentials (forcefield) derived from ab-initio 
calculations, or fit to experimental data. Molecular mechanics is commonly used when 
chemical interactions may be disregarded and only considers the physical aspect of the system 
which involves processes such as bond stretching, bond rotation and angle bending. 
Information on processes such as phase transitions, interactions of molecules with surfaces and 
protein dynamics can be obtained. The two methods mainly implemented to study system sizes 
of 102-103 particles and time scales of up to a few microseconds are Monte Carlo (MC) and 
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molecular dynamics (MD). Molecular mechanics provides accurate calculations of protein 
dynamics at a fraction of the computer resources compared to QM methods.  
Mesoscale modelling enables calculations of large complexes at much longer 
timescales by simplifying small groups of atoms into single interaction units (coarse graining). 
This method provides accurate representation of the macroscopic states of the system over 
longer time scales, where atomic accuracy is not required [151-153]. 
 
2.3  Molecular dynamics 
 
Molecular dynamics (MD) is one of the commonly used methods to study the time evolution 
of many particle systems with atomic precision and is the technique employed for the studies 
presented in this thesis. The dynamical behaviour of proteins is commonly studied by utilising 
MD methods because of better sampling efficiencies than other methods like MC [154]. The 
first successful application of the MD algorithm was performed on a system of hard spheres, 
as a model for atomic-scale systems [155, 156].  
 
2.3.1 Potential energy functions 
A forcefield (FF) is the common term in literature that refers to the form and parameters of 
mathematical functions that are used to describe the potential energy of a molecular system. 
General forcefields include terms describing the stretching of bonds, the bending of valence 
angles and the rotation of dihedrals, which are categorised as the bonded interactions and the 
electrostatic and van der Waals interactions, which are categorised as nonbonded interactions. 
All of these contributions can be described mathematically, with one of the possible FF 
examples given by: 
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(2.12)  Etotal   = Ebonds + Eangles + Edihedrals + Eelectrostatic + Evan der Waals  
 
where b is the bond length, θ is the bond angle, n is dihedral multiplicity, φ is the dihedral 
angle, σ is the dihedral phase, subscript 0 denotes equilibrium values of their respective 
properties; Kb, Kθ, Kφ are the force constants for the bond length, bond angles and dihedral 
terms respectively; q is the charge of the particle, D is the dielectric constant of a material, rij 
is the distance between the centres of particles i and j, εij is the minimum value of the van der 
Waals term, and Rmin is the radius of where the van der Waals term is at a minimum. 
 
2.3.1.1  Common forcefields 
There are a variety of forcefields that are optimised for certain types of molecules. The most 
common forcefields for biomolecular simulations are the AMBER [157], CHARMM [158] 
and GROMOS [159] forcefields. The AMBER forcefield has an additional bonded improper 
dihedral term which is necessary to maintain the chirality of the centre atom bonded to three 
other atoms. The improper dihedral term in the AMBER forcefield applies to planar groups 
with a periodicity of n = 2. The CHARMM and GROMOS forcefield both have an additional 
term for the improper dihedral energy which has a quadratic dependence on the value of the 
improper dihedral. The GROMOS forcefield is a united-atom forcefield where the hydrogen 
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and carbon atoms in methyl and methylene groups are treated as a single interaction point. It is 
especially important for the GROMOS forcefield to preserve chirality of the aliphatic carbon 
centres of which the hydrogen atoms are bonded to. The CHARMM forcefield is slightly 
different with the addition of a Urey-Bradley angle term. The inclusion of the improper 
dihedral and Urey-Bradley angle term provides the system additional degrees of freedom for 
an accurate reproduction of the vibrational spectra during parametrisation. Other variations in 
forcefields include scaling constants applied to the nonbonded interactions such as the 
Lennard-Jones and Coulomb interaction between atoms. 
Optimisation of the forcefield parameters involves fitting the parameter values to 
reproduce experimental or high level ab-initio data. The data used for optimisation ranges 
from experimental spectroscopy, crystallography data to data obtained from QM methods. 
Examples of parameters obtained from experimental data include vibrational spectra, 
solvation free energies, XRD structures, and from high level QM calculations - relative 
conformational energies and barrier heights. The AMBER [160], CHARMM [158] and 
GROMOS [159, 161] forcefields were extensively optimised for simulations of protein 
structures and dynamics. Multiple versions of each class of FF have been developed over the 
years and are still in use. New and improved versions continue to appear in literature, such as 
the AMBER11 [162], CHAMMc35b3 [163] and the GROMOS96 [164] forcefield.  
 
2.3.1.2  GROMOS96 forcefield 
The GROMOS96 forcefield is an improved version of the GROMOS87 forcefield [164] 
developed with particular emphasis on proteins and small molecules. It is not recommended 
for the use with long alkanes and lipids. The GROMOS96 forcefield was parameterised with a 
Lennard-Jones cut-off distance of 1.4 nm. 
Systematic comparisons between forcefields should be performed for any new system 
to be studied. For example, common FFs were extensively studied on chain B insulin [165]. 
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The study identified the GROMOS96 43a1 forcefield to produce structures consistent with 
NMR distance constraints with lower NOEs and fewer violations compared with other 
forcefields such as the AMBER and CHARMM forcefield. The all-atom forcefield 
CHARMM27 and the united-atom forcefield GROMOS96 43A1 was able to reproduce the 
experimentally observed dynamic behavior of chain B of insulin. Another study showed that 
generally, the GROMOS96 forcefield was capable of adequately sampling β-conformations 
and may be of particular advantage in the simulation of amyloid formations, although is less 
effective in sampling α-helical content [166].  
 
2.3.2 Bond constraint algorithms 
Optimisation of computational efficiency is one of the major factors to consider when 
simulating systems of various sizes. One way to enhance efficiency is to increase the time step 
used for each calculation. However, there is an inherent limitation with increasing the time 
step beyond 1 fs since hydrogen bond vibrations occur at that timescale. Fortunately, in most 
simulations the bond vibrations are not of interest, thus bond constraints such as the SHAKE 
[167] or LINCS [168] algorithm can be employed to increase the time step. 
The SHAKE algorithm is commonly used for large molecules, where the bonds and 
angles are reset to their prescribed values by a parallel shift in the direction of the bond. 
SHAKE is an iterative method that is numerically stable, however this method suffers from 
limitations of large displacements of the molecules caused by sequential bond considerations. 
The other commonly used bond constraint algorithm is the Linear Constraint Solver 
(LINCS). The constraints in this algorithm are explicitly reset and do not require matrix 
multiplications. This enables LINCS to handle large molecules with the same accuracy as the 
SHAKE algorithm at a fraction of the required time. 
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2.3.3 Periodic boundary conditions 
Particles that lie on the boundary of the simulation system undergo kinetic competition 
between the two interfaces. In order to accurately simulate systems in bulk fluid, the boundary 
effects must be eliminated. One of the ways to overcome this problem is to increase the system 
size so that we could mimic an “infinite” system in three dimensions. However, an increase in 
the system size is unfeasible due to the computational costs involved. A common approach is 
to utilise periodic boundary conditions (PBC) so that computational costs remain low whilst 
eliminating unwanted surface effects [169].  
PBC involve construction of a replica of the system in its three dimensions to generate 
an infinite lattice. There are a total of 26 ((33)-1) neighbours of any given system in three 
dimensions. A two dimensional illustration of how PBC are applied to a system is shown in 
Figure 2.2. As a particle drifts from the central simulation cell, it is replaced by a replica on 
the opposite side. This process occurs within all simulation cells simultaneously, ensuring that 
a constant number of particles remain in the system. Care must be taken to ensure that the 
simulation box size is large enough to avoid direct interaction between mirror images of the 
same atoms. 
 
 
Figure 2.2 – A two dimensional illustration of periodic boundary conditions. The central box highlighted in blue 
is the main simulation box. 
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2.3.4 Approximations for nonbonded interactions 
To calculate the correct forces acting on a particle, the contribution from all other particles and 
their replicas must be considered. Approximations for these corrections are usually employed 
as it is impossible in practice to correct for an infinite number of particles involved. A 
common approximation is the minimum size convention [170], where the nearest image of 
each particle is considered for the calculation of the short-range nonbonded terms. Another 
approximation is to implement a potential truncation using a cut-off so that interactions 
between all pairs of atoms that lie outside the cut-off value are automatically set to zero. This 
approximation is based on the assumption that neighbouring particles contribute to the 
majority of the potentials and forces, indicating that interactions between atoms separated by a 
distance larger than the specified cut-off are negligible. However, a small perturbation is 
introduced to the potential and force calculations and therefore a suitable cut-off must be 
chosen for the simulations. Inaccuracies in the long range electrostatic interactions can be 
corrected by several algorithms, the most accurate being the Ewald summation [171]. The 
Ewald algorithm treats the system as being infinitely periodic where particles interact with all 
other particles in the simulation box and with their images. The Ewald summation is 
computationally expensive to implement as it scales as the square of the number of particles in 
the central simulation cell. To alleviate this barrier, grid-based treatments like Particle-Mesh 
Ewald (PME) methods [172] were introduced, enabling cost efficient treatment of long-range 
electrostatic interactions [173, 174]. In the PME algorithm, the gridded charge densities of the 
nearest 27 points in three dimensions are used to calculate the potential through Gaussian 
distributions, where interpolation of the desired potential of each particle can be obtained. 
 
2.3.5 Solvation models 
Classical 3-site water models are commonly used for the simulation of biomolecular systems 
in a condensed aqueous environment. 3-site models have three interaction sites that correspond 
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to the three atoms of the molecule. A point charge is assigned to each atom in the molecule, 
with the addition of Lennard-Jones parameters on the oxygen atom. The simplicity and 
computational efficiency makes 3-site models appealing for MD simulations. The TIPS [175] 
and TIP3P [176] water models use a rigid geometry that matches the HOH angle of the water 
molecule of 104.52°, however the SPC [177] water model assumes an ideal tetrahedral 
geometry with an HOH angle of 109.47°. 
4-site water models assign a negative charge on an arbitrary point near the oxygen 
atom along the bisector of the HOH angle, improving the electrostatic distribution around the 
water molecule. The first 4-site model was the Bernal-Fowler model [178], with  a HOH angle 
of 105.7°. However, this model was unable to reproduce reasonable bulk properties of water, 
such as the density and heat vaporisation of water. This subsequently led to improved 
solvation models such as the TIP4P water model [176] and its variations such as TCP4P-Ew 
[179], TCP4P/Ice [180] and TCP4P/2005 [181]. Each solvation model was parameterised and 
tailored to specific studies: the TCP4P-Ew model tailored for studies involving Ewald 
summation methods; the TCP4P/Ice model tailored for the study of ice (as solid water); and 
TCP4P/2005 for studying the phase diagram of water. The TIP4P water model and its 
variations use the same HOH angle of the water molecular of 104.52°.  
An essential aspect in choosing a solvation model involves considering its 
compatibility with the biomolecular forcefield used. Forcefields are generally developed in 
conjunction with a specific water model for example the CHARMM and AMBER forcefields 
were developed with the TIP3P water model, while the GROMOS forcefield with the SPC 
model. An extensive comparison between the water models and its effects on thermodynamic 
properties [182] identified small differences in the hydration free energies.  
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2.3.6  Newton’s equations of motion 
The Born-Oppenheimer approximation enables the separation between nuclear and electronic 
coordinates due to the large difference in mass between the nuclei and the electrons [183]. The 
complete macroscopic state of the system can be described by the Hamiltonian of the system 
as a function of nuclear variables, as shown in equation 2.1: 
 
(2.1) H(q, p) = K(p) + V(q) 
 
where H is the Hamiltonian, K(p) is the kinetic energy as a function of momenta (p) of each 
atom, and V(q) is the potential energy as a function of the generalised coordinates (a) of the 
interatomic interactions.  
It is possible to construct Newton’s equations of motion based on the Hamiltonian. By 
solving the differential equations of Newton’s second law, the position, velocities and 
accelerations of the particles as a function of time can be obtained.  
 
(2.2)     2
2
dt
d
m
i
i
i rF
=      
 
where Fi is the total force experienced by each atom i, acting in the direction r, mi is the mass 
and ri is the position of atom i, respectively. 
The idea behind the MD approach is to calculate the positions and velocities at time t + 
δt, given the initial positions and velocities at time t. The time step δt is chosen such that it is 
smaller than the fastest vibration of the system and large enough to maximise computation 
efficiency (discussed in section 2.3.8).  
There are various techniques available to numerically solve equation 2.2 [184], the 
most commonly used being the Verlet algorithm [185]. The Verlet algorithm uses the positions 
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and accelerations at time t, and the positions from the previous step, r(t – δt), to calculate the 
new positions using equation 2.3: 
 
(2.3)    r(t + δt) = 2r(t) - r(t - δt) + δt2a(t) 
 
which is accurate within errors of the order of δt4. The velocities of the current step is 
calculated by using r(t - δt) and r(t + δt) to perform a Taylor series expansion about r(t): 
 
(2.4)    
t
tttt
t δ
δδ
2
)()()( −−+= rrv   
 
which is accurate within errors of the order of δt2. The lack of an explicit velocity term in this 
algorithm makes it difficult to obtain the velocities, which are not available until the positions 
have been computed at the next time step. 
The leapfrog algorithm [186] is a variation of the Verlet algorithm with the following 
relationships: 
 
(2.5) )
2
1()()( tttttt δδδ ++=+ vrr   
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1( tttttt avv δδδ +−=+    
 
In the leapfrog Verlet algorithm, the velocities )
2
1( tt +v  are first calculated from the 
velocities at time t - 
2
1
δt and the acceleration at time t. The positions r(t + δt) are then 
deduced from the velocities calculated together with the positions at time r(t) using equation 
2.5. The velocities at time t can then be calculated from equation 2.7: 
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(2.7)    v(t) = 
2
1 [v(t + 
2
1
δt) + v(t - 
2
1
δt)] 
 
This algorithm leaps over the positions to give their values at t + 
2
1
δt. The positions 
subsequently leap over the velocities to give their values at t + δt, providing the velocities at t 
+ 
2
3
δt. The velocities of this system are explicitly calculated and does not require calculation 
of the differences of large numbers compared to the Verlet algorithm. However, since the 
positions and velocities are not synchronised, the kinetic energy contribution to the total 
energy at the same time as the positions that are defined (from which the potential energy is 
determined), cannot be calculated.  
Another variation of the Verlet algorithm that offers improved accuracy and energy 
conservation is the velocity Verlet algorithm [187]. In this scheme, the positions and velocities 
are obtained from: 
 
(2.8)    r(t + δt) = r(t) + δtv(t) + 
2
1
δt2 a(t) 
(2.9)    v(t + δt) = v(t) + 
2
1
δt[a(t) + a(t + δt)] 
 
with the velocity computed at midstep using: 
 
(2.10)    v(t + 
2
1
δt) = v(t) + 
2
1
δta(t) 
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Once the forces and accelerations at time t + δt is calculated, the velocities at t + δt can 
be found with equation 2.11: 
 
(2.11)    v(t + δt) = v(t + 
2
1
δt) + 
2
1
δta(t + δt) 
 
2.3.7 Thermodynamic ensembles 
It is statistically impossible to determine the microstates of the system in MD because the 
properties of the system are continuous and not discrete. This can be alleviated using an 
ensemble approach, which involves bundling the microstates that lead to the same 
macroscopic properties such as temperature, volume or energy into a macrostate. Molecular 
dynamics can be performed under various conditions of constant number of particles (N), 
volume (V), pressure (P) and energy (E), i.e. different thermodynamic ensembles. The NVE 
ensemble (i.e. constant number of particles, volume and energy), known as the microcanonical 
ensemble, is composed of a set of microstates each with a complete description of a possible 
state of the system. A canonical ensemble is a distribution over the microscopic ensembles, 
where the average energy is constant. 
The canonical (NVT) ensemble involves a constant number of particles (N), volume 
(V), and temperature (T). This ensemble is commonly used to calculate thermodynamic 
quantities of a system under a fixed temperature. However, since laboratory experiments are 
usually carried out in ambient temperature and pressures, a more relevant and appropriate 
ensemble to consider would be the isothermal-isobaric (NPT) ensemble.  
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2.3.8 Temperature and pressure coupling 
It is necessary to control the temperatures of the simulated system for several reasons such as 
solute drift during equilibration and heating due to external frictional forces. Two widely used 
temperature coupling methods are the Berendsen [188] and Nosé-Hoover scheme [189]. 
The Berendsen temperature coupling algorithm mimics weak couplings with first-
order kinetics to an external heat bath with a given temperature. The advantage of this method 
is the versatility in which the rate of temperature decays can be controlled. It is a common 
algorithm to utilise for the relaxation of a system to a target temperature. The Berendsen 
thermostat suppresses the fluctuations of the kinetic energy which result in incorrect sampling 
of a proper canonical ensemble. For large systems however, most ensemble averages will not 
be significantly affected as the error is scaled inversely proportional to the number of particles 
under consideration. Although ensemble averages are not significantly affected, fluctuation 
properties such as the heat capacity are. 
The Nosé-Hoover temperature coupling algorithm provides correct information on the 
canonical ensemble. A thermal reservoir and a friction variable is introduced to the 
Hamiltonian of the system, enabling accurate mimics of the fluctuations in temperature for 
canonical ensembles. The friction parameter is a fully dynamic quantity with its own 
momentum and equation of motion. The time derivative is calculated from the difference 
between the current kinetic energy and the reference temperature. 
Similarly, the pressure coupling of a system needs to be considered to give correct 
representation of a molecular system. The two widely used methods are the Berendsen 
algorithm [188] and the Parrinello-Rahman approach [190], which are compatible with either 
temperature coupling algorithms. 
The Berendsen pressure coupling algorithm rescales the coordinates and box vector at 
each step of the calculation with first-order kinetic relaxation of the pressure towards a 
specified reference pressure. The fast kinetics of the systems are unaffected when utilising this 
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algorithm, which is the main reason as to why it is the preferred algorithm to achieve system 
equilibration. This algorithm yields the correct average pressure of the system rather than the 
exact NPT ensemble. 
The advantage of the Parrinello-Rahman algorithm is the correct representation of the 
fluctuations in pressure and volume in an NPT ensemble, thus accurate thermodynamic 
properties of the system can be determined. However, this algorithm yields large oscillations 
for systems far from equilibration. In this situation, the weak Berendsen coupling scheme is 
employed initially to reach the target pressure before switching to the Parrinello- Rahman 
coupling algorithm.  
 
2.4  Simulation methodologies 
 
The general procedure for system generation and simulations are described in this section of 
the thesis. Details such as specific simulation times, parameters employed and system 
composition and dimensions are described in the System Construction section of each chapter. 
The chosen forcefield for this thesis was the GROMOS96 43a1 as it was found to be 
suitable for studies involving spontaneous evolution of peptides and proteins [165]. The SPC 
water model was selected as the GROMOS96 43a1 forcefield was optimised using the SPC 
water model. 
All simulations were performed using the Gromacs 3.3 simulations package [191]. The 
starting structural coordinates of the apoC-II(60-70) peptide were obtained from a previous 
study carried out by A. Hung et al [89], utilising the GROMOS96 43a1 force field [161]. A 
topology file was obtained and a simulation box was generated with chosen dimensions. The 
simulation box was then filled with explicitly represented water molecules with a water 
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density of ~1.0g/cm3. Counterions were introduced to the simulation box to neutralise the 
system when solutes had a non-zero charge. 
Energy minimisation was performed on the constructed system to correct bad van der 
Waals contacts and steric clashes between the protein and water. The steepest descent first-
order minimisation method was applied to the system to reach a local energy minimum. The 
system was considered optimised (energy minimised) when a maximum convergence force 
was smaller than 1.0 kJ/mol/nm. 
Solvent equilibration simulations of 100 ps in length were performed on the energy 
minimised system in which the non-hydrogen atoms of the peptide were restrained with a 
harmonic potential, while all water molecules and counter ions were allowed to undergo free 
dynamics. Subsequently, un-restrained simulation trajectories of varying times were collected 
for data analysis. 
Analysis of the MD trajectories involved tools implemented in the Gromacs 3.3 
package. Visualisation and structural representation of the systems were performed using 
Visual Molecular Dynamics [192]. 
 
2.5  Analysis Techniques 
 
A variety of analysis techniques were used to quantify the structure and dynamics of the apoC-
II peptide and its cyclic derivative cyc(60-70). The analysis procedures were all carried out 
using the Gromacs 3.3 package. 
 
2.5.1  Cluster analysis 
The single-linkage clustering algorithm implemented in the Gromacs suite of analysis 
programs [193] was used to identify the most populated peptide conformations produced in the 
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course of the MD simulations. The structure with the highest number of neighbours not 
exceeding the cut-off value is taken as the centre of a cluster, and formed a cluster together 
with its neighbours. The structures of this cluster were thereafter eliminated from the pool of 
structures. The process was repeated until the pool of structures was empty, producing a series 
of non-overlapping clusters of structures. This technique suggests that a higher population of 
structures within a cluster indicates that they belong in a local minimum energy basin, and 
may suggest a higher degree of structural stability compared to clusters with a smaller number 
of members. 
 
2.5.2  Root mean square deviation 
The root mean square deviation (RMSD) of certain atoms in a molecule with respect to a 
reference structure can be calculated by least-square fitting the structure to the reference 
structure. This technique provides a qualitative measure of the structural variation as the 
simulation progresses. The RMSD can be obtained using the following formula: 
 
(2.13)     ∑
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where N is the number of atoms, rfinal(i) are the final coordinates of atom i, rinitial(i) are the 
initial coordinates of atom i, and t is time.  
 
2.5.3 Secondary structure evolution 
The STRIDE (Structural identification) algorithm [194] assigns secondary structure elements 
to a protein. The STRIDE algorithm uses hydrogen bond criteria implemented in the DSSP 
algorithm [195] and also includes dihedral angle potentials, providing higher accuracy than the 
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DSSP algorithm. It has been reported to correctly assign secondary elements in proteins in at 
least 70% of cases however, is believed to be less effective in assigning π-helices [196]. 
 
2.5.4 Radius of gyration 
Radius of gyration (rg) is a quantity that measures the distribution of atoms relative to their 
centre of mass. It is commonly used as a measure of the size and shape of the protein. For an 
unweighted value, it is calculated using the formula: 
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where N is the number of atoms, r(i) are the coordinates of atom i, and rcom are the coordinates 
of the protein’s centre of mass. 
 
2.5.5  Hydrogen Bonding 
Hydrogen bonding is an important mechanism in stabilising the secondary structure of a 
protein. The loss of an internal hydrogen bond can cause elements of the secondary structure 
to destabilise, resulting in protein unfolding. A hydrogen bond usually has an angle of 150°-
180° (θ) between the donor-hydrogen-acceptor atoms, and a donor-acceptor separation (r) of 
no further than 3.5 Å. A schematic representation of the hydrogen bonding criteria is 
illustrated in Figure 2.3 
 
Figure 2.3 – A hydrogen bond is formed (red) when certain criteria are fulfilled. D is the donor atom, A is the 
acceptor atom, and H is the hydrogen atom. 
r 
θ 
H 
D 
A 
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2.5.6 Solvent accessible surface area 
The solvent accessible surface area [197] is the area sampled by the centre of a probe tracing a 
protein’s van der Waals surface. The radius of the probe is set to 1.4 Å, which is 
approximately the radius of a water molecule. The solvent accessible area indicates the area 
available for a direct protein-solvent interaction or similar sized molecules. Under 
physiological conditions, hydrophobic residues will arrange themselves to reduce solvent 
exposure, however this may not be the case when the protein undergoes conformation 
changes. Hydrophobic interactions, especially those between aromatic side chains, have been 
shown to be important in amyloid aggregation and stability [198, 199].  
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Chapter 3 
 
 
 
 
3.  Investigation on the structure and dynamics of the 
cyclised apoC-II(60-70) peptide 
 
 
3.1  Chapter overview 
 
Protein aggregation has been associated with many debilitating diseases in the aging 
population. In particular, amyloid fibril formation by apolipoprotein C-II (apoC-II) has been 
linked to atherosclerosis. Furthermore, the short peptide fragment comprising residues 60 to 70 
in apoC-II (apoC-II(60-70)) has been identified as the core region responsible for the 
stimulation of amyloid fibril formation in solution. A potentially novel and effective way to 
combat amyloid formation by apoC-II involves introduction of a cyclised apoC-II(60-70) 
peptide (cyc(60-70)) into solutions containing the full-length, fibrillogenic protein. A detailed 
investigation of the structural and dynamical behaviours of cyc(60-70) will lay the 
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groundwork for the investigation of the mechanism behind amyloid fibril formation by apoC-
II(60-70).  
In this chapter, we conduct a conformational search via molecular dynamics (MD) 
simulations of the cyc(60-70) peptide under a variety of temperatures to investigate the most 
favourable structural features of the cyc(60-70) peptide. Additionally, we explore the structure 
and dynamics of the cyc(60-70) peptide using MD, compare our simulation results with 
experimental data and propose a mechanism by which cyc(60-70) may inhibit fibril formation. 
A scrambled sequence of the same amino acids of cyc(60-70) was also investigated to explore 
the effects of amino sequence specificity and its inhibition capabilities. This work was done in 
collaboration with Assoc. Prof. Geoff Howlett and his group from Bio21 Institute, who 
provided experimental data and results for comparison between the theoretical models. 
 53 
3.2 Introduction 
 
Protein folding is an important physical process where proteins adopt unique 3-dimensional 
structures specific to their roles. However under certain environments which deviate from 
standard physiological conditions, protein unfolding may occur and may promote their 
aggregation. Partially misfolded proteins can self-associate and form insoluble aggregates 
known as amyloid fibrils. The deposition of amyloid fibrils in the human body has been linked 
to many severe and debilitating neurological and systemic diseases. The development of 
agents that inhibit or reverse the formation of specific amyloid fibrils is a critical step in 
reducing the severity of such diseases. A possible therapeutic strategy to combat amyloid 
diseases involves the development of specific peptides that target the protein-protein interfaces 
inherent in amyloid fibrils.  
Peptide cyclisation strategies have been investigated in the past, which have provided a 
positive framework for the development of effective amyloid inhibitors [106-110]. The 
slightest alteration in interactions between intra-molecular domains may have drastic effects 
on fibril formation. For example, the addition of a lactam bridge between residues 17 and 21 
of Aβ(1-28) has been found to reduce cytotoxicity, and inhibit fibril formation by Aβ(1-40) 
[110]. 
ApoC-II is a very-low-density-lipoprotein and a physiological activator of lipoprotein 
synthesised in the liver and intestine. Amyloid fibril formation by human apolipoprotein C-II 
(apoC-II) has been extensively investigated (discussed in section 1.5) which offers a useful 
system to explore factors that control the rate of formation, morphology and stability of 
amyloid fibrils.  In the lipid-free state, apoC-II readily self assembles into fibrils with all of the 
defining characteristics of amyloid fibrils [89, 90, 138].  
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It has been shown that apoC-II(60-70) retains the ability to form fibrils [136], 
indicating the importance of elucidating the mechanism by which apoC-II(60-70) forms fibrils. 
ThT assays have indicated the cyclic derivative of apoC-II(60-70) to possess fibril inhibiting 
properties [88] however, there are currently no studies that characterise this potential amyloid 
inhibitor. In this chapter, we perform MD simulations to characterise the structure and 
dynamics of cyc(60-70) which will provide the framework for the investigation of the 
mechanism behind amyloid fibril formation and subsequently the inhibition of amyloid fibril 
formation by apoC-II(60-70). 
 
3.3  Conformational studies of the cyc(60-70) peptide 
 
To investigate the structure and dynamics of cyc(60-70), a conformational search was 
performed. The purpose of this investigation was to explore possible conformations of cyc(60-
70) and to identify structural features that the cyclic peptide could adopt. By subjecting the 
system to various temperatures (300K, 350K, 400K), the peptide may acquire sufficient 
energy to sample a wider range of conformations by escaping the local minima of the potential 
energy landscape. 
 
3.3.1 System construction 
A total of three MD calculations were performed using the force field parameter set 
GROMOS96 43a1 [161] with a time step of 2 fs. The electrostatic and Lennard-Jones 
interactions were calculated with a cut-off of 10 Å and long range interactions were treated 
using the PME method [172]. All bond lengths were constrained to their equilibrium values 
using the LINCS algorithm [168]. 
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The initial structure was obtained from a previous MD study on apoC-II(60-70) 
(60MSTYTGIFTDQ70) [89]. A heterodetic cyclic peptide was generated by a disulfide link 
between the N- and C- termini, generating a 13 residue cyclic derivative of apoC-II(60-70) 
(CN-60MSTYTGIFTDQ70-CC), as shown in Figure 3.1. Hereafter, the cyclised apoC-II(60-70) 
peptide is referred to as cyc(60-70). 
 
 
Figure 3.1 – A structural representation of the apoC-II(60-70) peptide before cyclisation (A) and after cyclisation 
(B). 
 
Each initial cyclic peptide structure was enclosed in a periodic box of 30 Å x 30 Å x 30 
Å, solvated with SPC water molecules that correspond to a water density of ~1.0 g/cm3 (~830 
SPC water molecules). Systems were energy minimised using the steepest descent method to 
reduce steric clashes. MD simulations were performed as an NVT ensemble. Constant 
temperature was achieved by coupling the system to a Berendsen thermostat [187] at 300K, 
350K and 400K. 100 ps of solvent relaxation was performed on the energy minimised system, 
where the peptide was restrained and the solvent was allowed to undergo free dynamics. 
Simulation trajectories of up to 84 ns for each system were collected for data analysis.  
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3.3.2  Results and discussion 
3.3.2.1  Secondary structure evolution  
The secondary structure evolution provides information on conformational changes that the 
peptide experiences over the simulation period. Specifically, the effects of temperature on the 
secondary structure in each simulation can be examined. The STRIDE algorithm (refer to 
Section 2.5.4) was used to assign secondary structure elements to cyc(60-70) over the entire 
simulation and is presented in Figure 3.2. 
 The 300K simulation of cyc(60-70) revealed a coil-strand-turn-strand-coil structure 
(Figure 3.2A) with the turn region being the apex (upper turn region) and the start-end coil 
being at the nadir (lower turn region). Each “side” of the peptide can be broken down into two 
strands, where strand one comprises Ser61-Tyr63 and strand two comprises Phe67-Asp69. A 
schematic representation of the regions is presented in Figure 3.3. The β-turn structure (strand-
turn-strand) was also identified in other MD studies on the linear analog of apoC-II(60-70) 
[84, 85, 89]. The β-turn region was postulated as a crucial structural element formed during the 
nucleation stage of fibril formation which is attributed to a stable hydrophobic core [84].   
 Examining the 350K simulation of cyc(60-70) reveals a more dynamic secondary 
structure evolution, which reflects increased flexibility due to an increase in temperature. The 
effects of increase in temperature can be observed by comparing the 350K plot to the 300K 
plot. The formation of a 3-10 helix is due to the reconfiguration of the aromatic side chain of 
Tyr63 which promotes the formation of a hydrogen bond between Tyr63 and CysC. This 
suggests that movements of the aromatic residues play an important part in the stabilisation of 
the peptide. 
 Inspection of the 400K simulation of cyc(60-70) reveals a reduction in extended 
conformations and an increase in turn motifs. Again, this is not surprising due to the relatively 
higher kinetic energy imposed by the increase of temperature. The aromatic residues are much 
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more dynamic under these conditions than in the 300K simulation, supporting the idea of the 
aromatic residues affecting the conformational stability of the peptide.  
  
Figure 3.2 - Secondary structure evolution for each simulation of cyc(60-70); A) 300K; B) 350K; C) 400K. The 
secondary structure colour codes: Cyan – turn; Yellow – extended conformation; Green – hydrogen bridge; White 
– coil; Blue – 3-10 helix; Red – π-helix. 
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Figure 3.3 – A schematic representation of the various regions in the cyc(60-70) peptide.  
 
3.3.2.2  Hydrogen bond analysis 
The increase in temperature of the three systems resulted in a higher number of although 
shorter-lived unique H-bonds. The 300K simulation was calculated to have an average of 4.7 
H-bonds per analysed frame (40 ps intervals) with 135 unique interactions. The 350K 
simulation was calculated to have an average of 4.2 H-bonds per analysed frame with 207 
unique interactions and the 400K simulation was found to have 4.0 H-bonds per analysed 
frame with 230 unique interactions. This indicates that increased temperature enables better 
conformational sampling efficiency which induces formation of additional short-lived H-
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bonds. In contrast, the results from the 300K simulation revealed fewer unique H-bonds but 
were more persistent (Figure 3.4A).  
The H-bond existence profile of the 300K simulation (Figure 3.4A) identifies three 
persistent H-bonds occurring between the two strands labelled by indices 21, 49 and 81, 
corresponding to Ser61(NH)-Thr68(O), Tyr63(NH)-Ile66(O) and Thr68(NH)-Ser61(O), 
respectively. The three H-bonds were identified to be H-bonds between the two-strands. The 
dissociation of the H-bonds between these two-strands after 68 ns indicates a significant 
conformational change, consistent with the results obtained from the 300K secondary structure 
evolution plot, which shows nearly complete loss of β-stranded content after 68 ns (Figure 
3.2A). 
Inspection of the H-bond existence profile of the 350K simulation (Figure 3.4B) 
reveals a consistent agreement with the secondary structure evolution plot of the 350K 
simulation. The H-bonds formed between the two-strands of the peptide dissociate, which can 
be related to conformation fluctuations between the time period of ~15-62ns. The dissociation 
event was identified to occur where Tyr63 orientated into a position that promoted the 
formation of a short-lived H-bond with CysN. This subsequently led to dissociation of 
hydrogen bonds between the two strands, enabling the central core region to become flexible. 
The three persistent H-bond indices are 31, 76 and 134, which correspond to Ser61(NH)-
Thr68(O), Tyr63(NH)-Ile66(O) and Thr68(NH)-Ser61(O), respectively. Interestingly, the 
three persistent H-bonds involve the same donor/acceptor pairs in the 300K simulation, 
suggesting that these bonds are particularly stable. Furthermore, the three persistent H-bonds 
that were identified initially, formed within the first 15 ns of the simulation, which dissociated 
and reformed after ~62ns. These results indicate that H-bonds between the two-strands play an 
important role in the peptide’s conformation stability.  
Examining the H-bond existence profile of the 400K simulation (Figure 3.4C) reveals 
that intra-peptide H-bonds are less persistent than those formed under lower simulation 
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temperatures. The semi-persistent H-bond indices are 38, 93 and 158, which correspond to 
Ser61(NH)-Thr68(O), Tyr63(NH)-Ile66(O) and Thr68(NH)-Ser61(O), respectively. Similarly, 
these H-bonds were persistent in the previous 300K and 350K simulations, further indicating 
that these inter-strand H-bonds play a significant role in the stability of cyc(60-70). However, 
it can be observed from Figure 3.4C that these H-bonds are significantly shorter-lived than 
those observed in the 300K and 350K simulations. This indicates that an increase in 
temperature (i.e. kinetic energy) induces high conformational fluctuations, in agreement with 
the secondary structure evolution plot of 400K. Thus, both hydrogen bond and secondary 
structure analyses, reveal that an increase in temperature leads to a decrease in persistence of 
H-bonds, which subsequently affects the conformational stability of the peptide and the 
peptide’s ability to adopt extended conformations (as defined by STRIDE). 
 
 
Figure 3.4A - H-bond existence map of the 300K simulation. Red lines indicate H-bond existence for particular 
interactions labelled by index, in order of initial appearance in trajectory. Persistent H-bonding exists up to ~68ns 
for indices 21, 49 and 81 which correspond to the H-bonds formed between Ser61(NH)-Thr68(O), Tyr63(NH)-
Ile66(O) and Thr68(NH)-Ser61(O), respectively 
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Figure 3.4B - H-bond existence map of the 350K simulation. Red lines indicate H-bond existence for particular 
interactions labelled by index, in order of initial appearance in trajectory. Persistent H-bonding exists for indices 
31, 76 and 134 however, is disrupted from ~15 ns to 62 ns. These three H-bonds reform after the long 
dissociation period and correspond to Ser61(NH)-Thr68(O), Tyr63(NH)-Ile66(O) and Thr68(NH)-Ser61(O), 
respectively 
 
Figure 3.4C - H-bond existence map of the 300K simulation. Red lines indicate H-bond existence for particular 
interactions labelled by index, in order of initial appearance in trajectory. The H-bonds are relatively shorter-lived 
at 400K. The three semi-persistent H-bonds are indices 38, 93 and 158, which correspond to Ser61(NH)-
Thr68(O), Tyr63(NH)-Ile66(O) and Thr68(NH)-Ser61(O), respectively 
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3.3.2.3  Cluster analysis 
The single-linkage clustering algorithm was used to examine the most frequently occurring 
conformations in the course of each MD simulation trajectory. Structures that were within a 
backbone RMSD cut-off value of 1.3 Å were classified as belonging to a cluster, where the 
average structure of this cluster is representative of the group. The clustering analysis utilised 
data at 40 ps intervals. The first and second most populated clusters from each simulation are 
shown in Figure 3.5. 
Cluster analysis of the 300K simulation identified 209 clusters. The two most 
populated clusters, hereafter designated as 300K-c1 and 300K-c2, appeared for 26.9% and 
15.6% of the time during the trajectory, respectively. The low number of identified clusters 
throughout the trajectory indicates a low conformational drift, consistent with both the 
secondary structure evolution plots and H-bond analysis. The two clusters share a common 
upper and lower turn region however; they seem to exhibit a flexible central core region, 
inclusive of the two-strands. The two-strands in 300K-c1 and 300K-c2 lie along the same 
extended axis, which promotes inter-strand backbone H-bonds via an elongation bias.  
Cluster analysis of the 350K simulation identified 1206 clusters. The two most 
populated clusters, 350K-c1 and 350K-c2, were found to exhibit populations of 4.8% and 
3.2%, respectively, significantly lower than the most populated clusters found in the 300K 
simulation. The significant increase in identified clusters and the significant decrease in 
population sizes indicate higher conformational drift in this system, consistent with the 
secondary structure evolution plots and H-bond profiles. The two clusters were found to 
exhibit an upper and lower turn region consistent with those obtained from the 300K 
simulation. The two-strands also lie on the same extended axis, promoting inter-strand 
backbone H-bonding to stabilise the conformation. Interestingly, 350K-c2 adopts a similar 
elongated conformation as 300K-c2. However, 350K-c1 adopts a bent, “C” shaped structure. 
 63 
Cluster analysis of the 400K simulation identified 1753 clusters, with the population 
size of the two most populated clusters 400K-c1 and 400K-c2 of 3.8% and 2.0%, respectively. 
Similarly to the 350K simulation, there is an increase in the number of identified clusters and 
a decrease in population sizes. The low cluster population can be attributed to the lack of H-
bonds, which are required for conformational stability. The upper and lower turn regions 
continue to remain consistent with the previous four clusters, indicating that most fluctuations 
occur in the central core region. The two-strands in each cluster continue to lie on an extended 
axis; however 400K-c2 adopts a “C” type structure similar to 350K-c1 albeit more 
pronounced. The 400K-c1 structure adopts similar, slightly extended conformation to 300K-
c1 with a “twist” along strand one. 
Cluster analysis reveals strikingly common structural features under various 
temperatures. The consistent upper (Thr64-Ile66) and lower turn regions (CysN and CysC) 
were identified in all simulations. Four of the six clusters were found to exhibit an extended 
conformation adopting a strand-turn-strand motif. The central core region exhibited a 
propensity for conformational drift, providing the peptide the flexibility to adopt a wide range 
of conformations.  
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Figure 3.5 - The number of clusters identified using an RMSD cut-off of 1.3 Å for each simulation is shown in 
the left of the figure. Structural representation of the two most populated clusters and their population are 
presented on the right. 
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3.3.2.4  Radius of gyration 
To further characterise the conformation of the cyclic peptide, the radius of gyration (Rg 
[x,y,z]) of the representative cluster structures were calculated to provide a description of the 
compactness of the peptide, shown in Table 3.1. This was achieved by measuring the 
distribution of the atoms relative to the centre of mass of the peptide with respect to its 
principal axis. The degree of elongation (r) can be measured by calculating the ratio of the 
largest axial radius of gyration (Rx) by the smallest axial radius of gyration (Rz). An 
elongation ratio of 1.00 suggests that the structure is globular and values larger than 1.00 
indicate that the structure is elongated. The radius of gyration of 300K-c1 and 300K-c2 are 
very similar, both exhibiting a consistent distribution along all three axes, indicating a similar 
compact conformation. Interestingly, the two “C” shaped structures (350K-c1, 400K-c2) were 
categorised as almost circular, with an elongation ratio of roughly 1.20.  The elongation ratios 
of the 300K clusters were significantly higher at circa 1.55. The two highest elongation ratios 
are the 300K-c2 and 350K-c2 structures, attributed to the overall elongated nature of the 
peptide and the “kink” that points downwards in the lower turn region. The elongation ratio 
was found to decrease as the temperature of the system increased, which further supports the 
lack of H-bonds leading to a more fluid central core region hence, a more globular shape. 
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 Rx Ry Rz Rg Elongation ratio 
 (Å) (Å) (Å) (Å)  
NMR1 6.04 5.72 3.78 6.46 1.59 
NMR4 5.92 5.61 4.03 6.43 1.47 
300K-c1 5.56 5.46 3.74 6.11 1.49 
300K-c2 5.77 5.66 3.51 6.23 1.64 
350K-c1 5.06 4.83 4.02 5.70 1.26 
350K-c2 6.37 6.12 3.52 6.73 1.81 
400K-c1 5.40 5.04 3.91 5.91 1.38 
400K-c2 4.83 4.57 4.15 5.54 1.16 
Table 3.1 - The radius of gyration Rg (x,y,z) of the six clusters. The elongation ratio is defined as Rx/Rz. 
 
3.3.2.5  Comparisons with NMR obtained structures  
The most populated cluster structures of the MD simulations were compared to the models 
obtained through solution NMR [88]. Of the twenty lowest energy structures, two distinct 
structures were chosen (NMR1 and NMR4) and used for comparisons (Figure 3.6). NMR1 
was identified to be similar in structure to the majority of the NMR structures; while NMR4 
exhibits a distinct shape different to NMR1.  
 
 
Figure 3.6 – The overlay of the twenty solution NMR structures (A), highlighting the two representative 
structures, NMR1 (partial structure shown in yellow) and NMR4 (partial structure shown in grey). The two 
representative structures NMR1 (B) and NMR4 (C) are explicitly shown. 
A B C 
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 The backbone root mean square deviation (RMSD) of the MD models with respect to 
the two NMR structures was calculated to quantify the resemblance between the simulated 
structures with those obtained by NMR (Table 3.2). Inspection of Table 3.2 reveals that the 
two NMR structures generally have a large backbone RMSD value of 2.0 Å with respect to the 
MD structures. The largest backbone RMSD value of 2.67 Å was between NMR4 and 350K-
c2 due to the extremely elongated shape of 350K-c2. The lowest backbone RMSD value of 
1.56 Å was between NMR1 and 400K-c1. Observations show large fluctuations in the central 
core region between the structures, evident in the large RMSD values. Furthermore, inter-
strand H-bonds were not identified in the NMR structures, indicating that the NMR structures 
adopt a wider range of conformations.  
The NMR structures were found to exhibit similar structural features identified through 
the MD models, despite the large differences in RMSD. In particular, the NMR structures 
exhibit the characteristic strand-turn-strand motif identified in previous studies [84, 85, 89], a 
similar upper turn region comprised of residues Thr64-Ile66, a similar lower turn region 
between the cysteine residues and a fluid flexible central core region. Additionally, the 
elongation ratios between the NMR structures were calculated to be approximately 1.55, 
similar to the two most populated clusters in the 300K simulations. These structural features 
have been observed in both NMR and MD models, which suggest they are common structural 
features of cyc(60-70). 
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 RMSD (Å) 
 NMR1 NMR4 
300K-c1 2.32 2.46 
300K-c2 2.48 2.52 
350K-c1 1.86 2.01 
350K-c2 2.47 2.67 
400K-c1 2.06 2.21 
400K-c2 1.56 1.79 
Table 3.2 – The backbone RMSD of each MD structure with respect to the two NMR structures. 
 
3.3.3 Conclusion 
In this section, the conformational landscape of cyc(60-70) was explored by simulating the 
system at different temperatures. It was identified that an increase in temperature contributed 
to high conformational fluctuations in the cyc(60-70) peptide. The conformation fluctuations 
were a result of the dissociation of inter-strand H-bonds between the backbone of the cyclic 
peptide.  
 Although the conformations of the cluster structures varied, there were a number of 
consistent features that were identified from both MD simulations and NMR spectroscopy. 
Regardless of the temperature, the upper turn region was found to be located at Thr64-Ile66. 
Structures were observed to adopt a strand-turn-strand motif which was hypothesised to be an 
important feature of the peptide during the nucleation stage of fibril formation [84]. A 
consistent lower turn region suggests the peptide preferentially adopts an elongated structure, 
as shown through cluster analysis. The two-strands were found to preferentially adopt an 
extended conformation at 300K, promoting H-bonds between the backbone strands to increase 
stability. However, the inter-strand H-bonds show a tendency to unravel as the temperature is 
increased. H-bonds between the backbone of the strands were found to be persistent at 300K 
and 350K with a low unique H-bond count. Conversely, H-bonds were short lived at higher 
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temperatures, indicating a higher conformational sampling efficiency. It is important to note 
that the same persistent inter-strand H-bonds were identified in all the simulations 
(Ser61(NH)-Thr68(O), Tyr63(NH)-Ile66(O) and Thr68(NH)-Ser61(O)), indicating the 
importance of these H-bonds and their role in the peptide’s structural stability. This can be 
further observed in the NMR structures where the lack of these inter-strand H-bonds resulted 
in a greater structural variation in the central core region. The elongation ratio of the two NMR 
structures and the two 300K cluster structures was found to be circa 1.55 which was identified 
to be inversely proportional to the kinetic energy (i.e. temperature) of the system.   
 The consistent features identified through this study will provide the framework for the 
investigation of the structure and dynamics of cyc(60-70) in the following sections. 
 
3.4 Structure and dynamics of cyc(60-70) and scram(60-70) 
  
In this section, we extend the work on the conformational characteristics of cyc(60-70) by 
investigating and comparing the structure and dynamics of cyc(60-70) at room temperature to 
those obtained by NMR. The simulations described in this section were performed for a longer 
period compared to those described in Section 3.3 (500 ns compared to 84 ns, respectively), 
enabling a better sampling of the room temperature dynamics of the peptides. 
 
3.4.1 System construction 
The Gromacs 3.3 simulation package was employed for all MD simulations and analysis of 
results. The MD calculations were performed using the force field parameter set GROMOS96 
43a1 under NVT conditions at 300 K. Three initial conformations were used for the MD study 
of cyc(60-70). Two initial structures NMR1 and NMR4, were taken from a pool of twenty 
averaged solution NMR structures (labelled according to their order in the NMR ensemble, 
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Figure 3.7 A). The final conformation, MD1, was the same peptide used in the previous 
section. The peptide was extracted from a previous MD study (60MSTYTGIFTDQ70) [89] of 
the linear apoC-II(60-70) peptide, which was cyclised by the introduction of cysteine residues 
at the N- and C- termini, linked by a disulfide bond, as shown in Figure 3.1.  
To ascertain whether the inhibitory activity of cyc(60-70) was sequence specific, a 
scrambled cyclic peptide (scram(60-70)) was synthesised, and its capacity for fibril inhibition 
experimentally probed [88]. It was revealed that scrambling the sequence of the peptide 
significantly impaired its inhibitory activity, suggesting that the inhibition of fibrillisation is 
sequence specific. To investigate and compare the structure of the cyc(60-70) to scram(60-70), 
the scrambled cyclic peptide (CN-60IFGMDTTSQTY70-CC) model was also constructed. The 
initial structure of scram(60-70) was generated starting from an extended conformation using 
Discovery Studio 3.0 Visualiser. MD simulation of 5 ns was performed to allow the peptide 
structure to equilibrate, which readily folded into a hairpin-like conformation with the N- and 
C-termini in close proximity. The peptide was then cyclised by a disulfide bond (scram(60-
70), Figure 3.7 E) before undergoing a further 500 ns of MD simulation. 
Each initial cyclic peptide structure was enclosed in a periodic box of 30 Å x 30 Å x 30 
Å, solvated with SPC water molecules corresponding to a water density of ~1.0 g/cm3 (~820 
SPC water molecules). Systems were energy minimised using the steepest descent method to 
reduce steric clashes. Temperature was controlled by coupling the system to a Berendsen 
thermostat. The time step for all simulations was set to 2 fs. Solvent equilibration simulations 
of 100 ps in length were performed on the energy minimised system in which the non-
hydrogen atoms of the peptide were restrained with a harmonic potential, while all water 
molecules and counter ions were allowed to undergo free dynamics. Subsequently, 
unrestrained simulation trajectories of 500 ns for each system were collected for data analysis. 
The results of three 500 ns simulations with alternative starting structures (NMR1, NMR4, and 
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MD1) were considered as an ensemble consisting of a simulation time of 1.5 µs. Figure 3.7 
presents the initial structures and naming conventions of the simulated systems. 
 
 
Figure 3.7 - The four starting structures used in the MD simulations. (A) Overlay of the twenty averaged solution 
NMR structures of cyc(60-70) from which two were picked; NMR1 (partial structure shown in yellow) and 
NMR4 (partial structure shown in grey). Details of starting structures employed in MD simulations are shown for 
(B) NMR1, (C) NMR4, (D) MD1, and (E) scram(60-70) [88]. 
A 
B C 
D E 
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3.4.2 Results and discussion 
3.4.2.1  Dynamics and conformation populations of cyc(60-70) 
The single-linkage clustering algorithm was used to examine the most frequent occurring 
conformations in the course of each MD simulation. The backbone RMSD cut-off value of 1.3 
Å was specified. The most populated cluster and its corresponding population size is shown in 
Figure 3.8.  
 
 
Figure 3.8 - Structural representation of the highest populated structure obtained from cluster analysis of the 
ensemble trajectory with a backbone RMSD cut-off of 1.3 Å and its corresponding population.  
 
The cluster analysis of the ensemble trajectory (taken at 120 ps intervals) of the 
cyc(60-70) peptide identified 4451 distinct clusters. The representative structure of the most 
populated cluster, ensem-c1 shows the presence of a β-hairpin conformation, consistent with 
the β-hairpin conformation observed in the previous section and its linear form [85, 89, 90].  
The most populated cluster comprises 13.8% of the total structures generated in this simulation 
with subsequent clusters having a population of less than 5.0%.  
ensem-c1  
(13.8%) 
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The backbone RMSD between ensem-c1 and NMR1 and NMR4 was 2.88 Å and 3.00 
Å, respectively. The RMSD values show such a disparity as a result of its flexibility, 
particularly in its central core region. Additionally, a large pool of identified clusters (4451) 
with low corresponding population sizes suggests that constraining the apoC-II(60-70) peptide 
at the N- and C- termini alters the stability, kinetics and dynamics drastically in comparison to 
its MD simulated linear form [89]. In Section 3.3, the peptide was characterised with a 
dynamic central core region which provides the structural flexibility of cyc(60-70). The 
structural flexibility of cyc(60-70) can be further highlighted in Figure 3.9, where the 
subsequent nine clusters exhibiting a population size with an upper and lower bound of 5.0% 
to 1.0% are shown. Interestingly, the upper and lower turn regions remain consistent in these 
nine cluster structures.  
Perhaps the most striking feature of ensem-c1 is the stacking of the aromatic rings. The 
NMR structures also exhibited rings on the same side of the peptide, adopting a conformation 
that displays a distinct hydrophobic and hydrophilic face. The significance of aromatic ring 
interactions will be discussed in section 3.4.2.2. Other striking features that this structure 
exhibits are an elongation to a single axis, β-hairpin conformation at the upper turn region 
(Thr64, Gly65, Ile66) similar to its linear counterpart, the formation of a loose hydrophobic 
region and the stabilisation of the peptide through multiple inter-strand hydrogen bonds. Most 
but not all of these structural elements were initially identified in the conformation search 
study. 
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Figure 3.9 - Structural representation of the other nine clusters with a population size > 1.0%.  
 
The radius of gyration and the degree of elongation were also analysed (shown in 
Table 3.3). The distribution of the atoms relative to the centre of mass of the peptide with 
respect to its principal axis was measured to provide a description of the compactness of the 
peptide. The degree of elongation (r) can be measured by calculating the ratio of the largest 
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axial radius of gyration (Rx) by the smallest axial radius of gyration (Rz). An elongation ratio 
of 1.00 suggests that the structure is globular and values larger than 1.00 indicate that the 
structure is elongated. The radius of gyration of NMR1, NMR4, and ensem-c1 are very similar 
showing no difference larger than 1.9%. The elongation of the three structures along the x, y, 
and z axes is also very similar on average (circa 6.00, 5.80, 3.70 Å, respectively), and all adopt 
an elongated conformation with an elongation ratio of approximately 1.60. The degree of 
elongation is in agreement with what was obtained from the conformational study at 300K 
(Section 3.3). 
 
 Rx Ry Rz Rg Elongation ratio 
 (Å) (Å) (Å) (Å)  
NMR1 6.04 5.72 3.78 6.46 1.59 
NMR4 5.92 5.61 4.03 6.43 1.47 
ensem-c1 6.13 6.00 3.50 6.55 1.75 
Table 3.3 - The radius of gyration Rg (x,y,z) of the structures. The elongation ratio is defined as Rx/Rz [88]. 
 
Previous MD simulations studies indicated that both apoC-II(60-70) and apoC-II(56-
76) favour hairpin-like structures in solution, which are assumed to mediate intermolecular 
interactions leading to aggregation, but must significantly alter their conformation to allow 
aggregation to proceed [84, 85, 90]. A high degree of structural flexibility indicates that 
cyc(60-70) can undergo these significant conformational changes to maximise hydrophobic 
interactions, which may subsequently promote a fibril inhibiting environment. Additionally, 
preferential bias toward elongated conformations suggests cyc(60-70) can adopt a “capping” 
conformation, resulting in a mechanism similar to the effects of short-chain phospholipids 
shown previously [89, 90, 146, 147]. 
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3.4.2.2  Cyc(60-70) exhibits propensity to form hydrophilic/hydrophobic faces 
Hydrophobic interactions, especially those between aromatic side chains, have been shown to 
be important in amyloid aggregation and stability [198, 199]. Using site-directed 
modifications, aromatic residues were identified to play a crucial role in the fibrillisation 
process [200]. The mutation of Phe to Ala in the IAPP motif (22NFGAIL27, 14NFLVH18) was 
shown to significantly reduce fibril formation. Conversely, replacement of any residue other 
than Phe in these two fragments had no effect on fibril formation [201]. Similarly, the 
mutation of Phe to Ala in human calcitonin completely inhibited the formation of amyloid 
fibrils [202]. These results give reason to suggest that the presence of the two aromatic rings 
(Tyr63 and Phe67) in apoC-II(60-70) can facilitate or drive aggregation. Furthermore, studies 
recently identified distinct differences in aromatic side-chain orientations between the peptide 
under fibril forming and fibril inhibiting conditions [85, 89]. 
To characterise the relative orientation between the two aromatic rings, the average 
angle between the Cα-Cγ vector of Tyr63 and the Cα-Cγ vector of Phe67 was calculated. 
Angles less than 90° indicate that the side-chains exist on the same side of the peptide while 
angles greater than 90° indicate that the rings lie on opposite sides of the peptide. A previous 
study on this peptide revealed that under fibril-inhibiting conditions, the aromatic rings adopt 
structures where Tyr63 and Phe67 lie on the same side, whereas the structures obtained under 
fibril-favouring conditions favour aromatic rings on opposing sides of the hairpin [89]. The 
histogram and representative structure obtained from the ensemble simulation are presented in 
Figure 3.10. 
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Figure 3.10 – A histogram of the Tyr63 and Phe67 relative aromatic ring orientation (X-axis) obtained from the 
ensemble trajectory. The percentage of structures (Y-axis) with respect to their angles (X-axis) is shown. A total 
of forty-one bins were used over the range 0 – 180°, with each data point corresponding to an angle interval of 
4.5°. Angle < 90° indicates both rings are on one side of the peptide, while > 90° indicates rings exist on opposite 
sides. Structures illustrating the relative ring orientations are represented in insets. 
 
Inspection of Figure 3.10 reveals that cyc(60-70) adopts conformations that possess 
both fibril inhibiting and fibril forming abilities, indicating a high degree of structural 
flexibility. Tyr63 was observed in Section 3.3 to preferentially interact with hydrophobic 
residues, particularly with the hydrophobic core of cyc(60-70) which may account for the high 
percentages of structures located at a relative orientation greater than 90° (Figure 3.10) due to 
fluctuations around the upper turn region. Additionally, Met60 is commonly found located 
distal to the hydrophobic core, which promotes fluctuations of the aromatic side chains of 
Tyr63. Interaction between Tyr63 and the lower turn region resulted in a significant 
conformational change, subsequently altering the orientations between the aromatic side-
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chains. However, it can be postulated that the aromatic side-chains will stabilise and adopt a 
conformation where the relative orientations between the aromatic side-chains are less than 
90° (fibril inhibiting) when interacting with another peptide, to form a larger local 
hydrophobic core.  
Despite the aromatic side-chains facing opposite sides, cyc(60-70) exhibits a 
propensity to interact with other hydrophobic residues, retaining a loose hydrophobic zone 
(Figure 3.11). It is believed that the hydrophobic interactions are the main driving force that 
facilitates fibril formation [3, 4, 6, 85, 91, 146, 147, 198, 199].  
 
 
Figure 3.11 - Ribbon representation of a structure with a relative aromatic side-chain orientation of 139.5° (A) 
and the explicit representation of the hydrophobic (green) and hydrophilic residues (purple) (B), highlighting the 
presence of a loose hydrophobic zone. 
 
3.4.2.3  Solvation properties of cyc(60-70) 
A recent study highlighted solvent effects on the structured states of amyloidogenic peptides 
that may result in fibril formation or inhibition [203]. The Aβ(25-35) peptide was found to 
preferentially adopt helical structures in apolar organic solvents which were postulated to 
possess fibril inhibiting abilities. Conversely, in water, the peptide adopted collapsed coil and 
A B 
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β-hairpin conformations which were shown to form fibrils. The solvent environment is 
therefore likely to influence the solvent accessibility (i.e. exposure) of various residues 
(particularly aromatic residues) of the peptide, which may subsequently strongly influence the 
capacity of the peptide to oligomerise, or bind to existing oligomers. Therefore the solvent 
accessibility of the residues of the cyc(60-70) peptide is crucial in determining the possible 
mechanism behind fibril inhibition. 
To determine the exposure of various residues of cyc(60-70), the solvent accessible 
surface area (SASA) per residue of NMR1, NMR4, and ensem-c1 were calculated by using a 
probe radius of 1.4 Å with atom surfaces defined by the Lennard-Jones hard shell radii (Figure 
3.12).  For comparison, the SASA of the linear apoC-II(60-70) peptide [89] is also presented.  
The general features of the solvation properties of the cyclic structures are similar to 
those of the linear counterpart. Residues Ser61, Gly65 and Thr68 exhibited low solvent 
accessible area, while Met60, Tyr63 and Phe67 were highly exposed (Figure 3.12). The region 
near the C-terminus (Thr68-Gln70) displays erratic solvent exposures, attributed to the “kinks” 
in the lower turn region near the disulfide bond.  
It was suggested that high solvent exposure of the β-turn region could be responsible 
for initiating fibril aggregation [85]. Interestingly, all cyclic structures had a lower solvent 
exposure in the β-turn region (Thr64, Gly65, Ile66) in comparison to the linear analog, 
indicating a possible fibril inhibiting characteristic of cyc(60-70). However, the solvent 
exposure of Tyr63 in all structures was significantly higher than its linear counterpart. 
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Figure 3.12 - The solvent accessible surface area of each residue for each cyclic peptide structure with the 
inclusion of linear apoC-II(60-70); NMR1 (black line), NMR4 (grey line), ensem-c1 (blue line), and apoC-II(60-
70) (orange line).  
 
3.4.2.4 Structure and properties of scram(60-70) 
MD simulation of scram(60-70) (starting structure Figure 3.7 E) was performed over 500 ns to 
investigate the structure and dynamics of this peptide. Experimental data suggest that fibril 
formation by apoC-II(60-70) was sequence specific, indicated by the lack of inhibition activity 
of the scrambled apoC-II(60-70) peptide (CN-60IFGMDTTSQTY70-CC) [88]. Investigating the 
differences in structure and dynamics may provide further insight towards the mechanism 
behind inhibition. 
Cluster analysis of the backbone of the scrambled peptide (1.3 Å cut-off, taken at 120 
ps intervals) identified 354 unique clusters. The highest populated cluster, scram-c1, had a 
population of 48.8% whilst the second most populated cluster had a population of 31.6% 
(Figure 3.13). The significant decrease in unique clusters and the increase in cluster population 
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size of scram-c1 and scram-c2 in comparison to ensem-c1 indicates that scram(60-70) has a 
higher overall structural stability, and a reduced ability to adopt alternate conformations that 
are required to maximise hydrophobic interactions. Close inspection of the scrambled 
sequence (Figure 3.14) indicates structural features that may be sequence specific. 
 
Number of 
clusters 
Structure and population of the two most 
populated clusters 
scram 
(354) 
 
               c1 - 48.8%                  c2 - 31.6% 
             
 
Figure 3.13 - The number of clusters identified using an RMSD cut-off of 1.3 Å for the scrambled simulation is 
shown in the left of the figure. Structural representation of the two most populated scrambled clusters and their 
population are presented on the right. 
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Figure 3.14 - A schematic representation of the scrambled apoC-II(60-70) peptide, scram(60-70) (CN-
60IFGMDTTSQTY70-CC). The inherent propensity of Tyr to interact with hydrophobic residues forces a collapse 
in structure between residues Phe and Tyr (Ile, CysN, CysC ).  
 
From the conformational study in Section 3.3, we identified the relative orientation of Tyr63 to 
play a crucial part in conformational reconfiguration. Analysing the sequence of the scrambled 
peptide reveals a sequential four residue hydrophobic region (Ile, Phe, Gly and Met) with Tyr 
located distal from the hydrophobic region. The turn region is mediated by the turn motif 
adopted by Gly. The propensity of Tyr to interact with the hydrophobic region forces a 
collapsed coil motif in secondary structure at residues Ile, CysN and CysC, resulting in a helix-
like bend. While the aromatic side chains of Tyr and Phe are located close to one another in 
Met Cα 
CysN Cα 
Ser Cα 
Thr Cα 
Thr Cα 
Tyr Cα 
Ile Cα 
Gly Cα Phe Cα 
Thr Cα 
Asp Cα 
Gln Cα 
CysC Cα 
Hydrophobic Core Region 
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scram-c1 and scram-c2, these side chains are distal to both Met and Ile and do not form the 
large hydrophobic surface observed for cyc(60-70) (Figure 3.15). 
 
 
Figure 3.15 - Ribbon representation of scram-c1 (A) and scram-c2 (C) and their corresponding explicit 
representation of the hydrophobic (green) and hydrophilic residues (purple) (B, D, respectively). 
 
Scram-c1 and scram-c2 has been found to exhibit consistent Rg [x,y,z] and elongation 
values. Both structures were found to be significantly more compact than NMR1, NMR4, and 
ensem-c1. The axial radius of gyration of scram-c1/c2 was lower in the x and y axes and 
higher in the z-axis when compared to NMR1, NMR4, and ensem-c1 (Table 3.4), indicating 
that both scram-c1 and scram-c2 are more spherical in nature (elongation ratio circa 1.30). The 
A B 
C D 
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lower elongation ratio is in agreement with the postulation of Tyr interacting with the 
hydrophobic region, “flattening” the overall structure of the peptide.    
 
Table 3.4 - The radius of gyration Rg (x,y,z) of the scram-c1 and scram-c2 structures along with their 
corresponding elongation ratio (defined as Rx/Rz). The NMR1, NMR4 and ensem-c1 structures have been 
included for convenience. 
 
Analysis of the scram(60-70) trajectory showed that structural stabilisation of the 
peptide was mediated by a 55% increase in the number of intra-molecular hydrogen bonds 
compared to the cyc(60-70) ensemble trajectory. The formation of a H-bond between Thr 
(closest to Tyr) and the backbone NH of Ile was common in both scram(60-70) structures. 
Additionally, scram-c1 showed highly solvent exposed aromatic rings (Tyr63 and Phe67) with 
low solvent exposure at Gly65, a trend similar to NMR1, NMR4, and ensem-c1 (Figure 3.12). 
Scram-c2 also showed highly solvent exposed aromatic rings however, the solvent exposure of 
Gly was slightly higher (Figure 3.16).  
 
 Rx Ry Rz Rg Elongation ratio 
 (Å) (Å) (Å) (Å)  
scram-c1 5.44 4.88 4.23 5.97 1.29 
scram-c2 5.56 4.86 4.2 6.04 1.32 
NMR1 6.04 5.72 3.78 6.46 1.59 
NMR4 5.92 5.61 4.03 6.43 1.47 
ensem-c1 6.13 6.00 3.50 6.55 1.75 
 85 
 
Figure 3.16 – The solvent accessible surface area of each residue for the two scrambled cluster structures with the 
inclusion of linear apoC-II(60-70). Per residue solvent accessible surface area is shown for scram-c1 (red dotted 
line); scram-c2 (green dotted line); and apoC-II(60-70) (orange line). The sequence of scram(60-70) was 
“unscrambled” back to its native sequence. 
 
3.4.3 Conclusions 
The results of these studies show that cyc(60-70) is extremely flexible, which may be an 
important feature for an inhibitor of peptide aggregation. The general conformational features 
of cyc(60-70) identified through extensive sampling were found to be consistent with those 
identified in Section 3.3. The peptide was identified to exhibit a characteristic strand-turn-
strand conformation with consistent upper and lower turn regions, preferentially adopting 
extended conformations with an elongation ratio of circa 1.55. The peptide also showed a 
preference to form distinct hydrophobic and hydrophilic faces due to a strong preference to 
same-side position of aromatic residues. Inhibition activity was identified to be largely 
sequence specific. 
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Scrambled peptide simulation results suggest that scram(60-70) exhibit substantially 
different conformations with significantly reduced flexibility. Scram(60-70) was identified to 
exhibit a more globular, compact conformation which was stabilised by intra-molecular 
hydrogen bonding. Thus, while the aromatic side chains (Tyr63 and Phe67) were grouped on 
one side of the structure, the hydrophobic surface presented by scram(60-70) was relatively 
smaller, which may subsequently reduce the peptide’s ability to adopt conformations that 
allow efficient interaction with the fibrillogenic peptides.  
The structural features and dynamics identified in both Sections 3.3 and 3.4 will 
provide insight towards explaining how cyc(60-70) may inhibit amyloid fibril formation by 
apoC-II(60-70) (discussed in Chapter 4). 
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Chapter 4 
 
 
 
 
4.  Investigating the interactions between cyclic and 
linear apoC-II(60-70) peptides 
 
 
4.1  Chapter overview 
 
In this chapter, the interactions between the cyclic derivative of apoC-II(60-70), cyc(60-70) 
and its linear apoC-II(60-70) analog in a β-hairpin conformation [89] are studied in detail to 
provide molecular level understanding of the mechanism behind amyloid fibril inhibition by 
cyc(60-70). The structure and dynamics of the cyclic inhibitor, cyc(60-70) was previously 
characterised in Chapter 3. In this chapter, the work is extended by studying the effects of 
cyc(60-70) on lin(60-70) that prevents it interacting with like-peptide aggregates at atomic 
resolution through molecular dynamics (MD) simulations. Based on the results from this 
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study, a mechanism is proposed by which cyc(60-70) inhibits amyloid fibril formation by 
apoC-II(60-70). 
 
4.2  Introduction 
 
Many severe and debilitating neurological disorders have been associated with the deposition 
of amyloid fibrils in the human body. It is therefore imperative to develop therapeutic agents 
that inhibit or reverse the formation of specific amyloid fibrils. A possible therapeutic strategy 
to combat amyloidosis involves the development of specific small peptides that target the 
protein-protein interfaces inherent in amyloid fibrils. A novel strategy involving constrained 
forms of small peptides [106-110, 200] (discussed in Section 1.5), such as the addition of a 
lactam bridge between residues 17 and 21 of Aβ(1-28), has been shown recently to possess 
potential amyloid inhibitory activity [110]. 
Human apolipoprotein C-II (apoC-II) is a 79 residue peptide previously discussed in 
Section 1.5. It was previously shown that the peptide containing residues 60 to 70 of apoC-II 
retains its ability to form fibrils [134]. Preliminary results obtained from experiments [88] 
have indicated that cyclised apoC-II(60-70) (cyc(60-70)) inhibits fibril formation by apoC-
II(60-70). 
In Chapter 3, the structure and dynamics of cyc(60-70) was characterised through MD 
simulations and compared to solution NMR structures. Several unique structural features of 
cyc(60-70) were identified, such as a flexible central core region, an elongation bias and a 
characteristic strand-turn-strand motif (β-turn). The β-turn structure has been commonly 
identified in previous MD simulation studies of apoC-II(60-70) [84, 85, 89], indicating that 
this defining characteristic could possibly be involved in formation of intermediates in the 
fibril forming process, by facilitating the earliest inter-molecular interactions on the 
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aggregation pathway. Despite preliminary experimental data indicating that cyc(60-70) 
exhibits fibril inhibiting activity, the mechanism of the inhibition is not well understood. 
Exploring the interactions of cyc(60-70) and its linear apoC-II(60-70) analog could therefore 
provide insight towards a possible inhibition mechanism. In this chapter, we extend the work 
by performing MD simulations on the β-turn amyloidogenic apoC-II(60-70) peptide, lin(60-
70) and the identified fibril inhibitor, cyc(60-70). This study will characterise the interactions 
that occur between cyc(60-70) and lin(60-70), which may shed some light on the mechanism 
by which cyc(60-70) inhibits amyloid fibril formation by apoC-II(60-70). 
 
4.3 System construction 
  
The MD calculations were performed using the force field parameter set GROMOS96 43a1 
under NPT conditions at 300K. Eight different initial arrangements of the linear-cyclic dimers 
of apoC-II(60-70) were generated (Figure 4.1). Four simulations utilised the 11 residue β-turn 
linear peptide (60MSTYTGIFTDQ70) extracted from the previous study [89], whilst the 
remaining four simulations utilised the native conformation of the 11 residue sequence 
extracted from the NMR structure of apoC-II (PDB code 1SOH). The cyclic structure was 
taken from the most populated cluster in the previous MD simulation (Chapter 3, ensem-c1) 
and was placed ~7 Å apart from the linear apoC-II(60-70) peptide. The 8 simulations were 
then concatenated into an ensemble trajectory of 2.8 µs. 
 We have labelled the linear apoC-II(60-70) peptide [89] in the heterodimer complex as 
lin(60-70) to avoid confusion with the isolated linear apoC-II(60-70) peptide. 
Each initial dimer complex was enclosed in a periodic box of 60 Å x 60 Å x 60 Å, 
solvated with SPC water molecules corresponding to a water density of ~1.0 g/cm3 (~7020 
SPC water molecules). Systems were energy minimised using the steepest descent method to 
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reduce steric clashes. Simulation conditions of constant temperature at 300 K and constant 
pressure of 1 bar was achieved by coupling the system to a Berendsen thermostat and barostat, 
respectively. The time step for all simulations was set to 2 fs. Solvent equilibration simulations 
of 100 ps in length were performed on the energy minimised system where the peptide was 
restrained and the solvent was allowed to undergo free dynamics. Subsequently, un-restrained 
simulation trajectories of 350 ns for each system were collected for data analysis. 
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Arrangement Schematic Structural representation 
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Figure 4.1 – The eight initial arrangements of the peptides, including its schematic and structural representations 
prior to MD simulations. Arrangements 1 to 4 comprises the β-hairpin conformation identified from our previous 
study [89] and arrangements 5 to 8 comprises apoC-II(60-70) in its native conformation. 
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4.4  Results and discussion 
 
4.4.1 Lin(60-70) stabilises cyc(60-70) 
Cluster analysis of the ensemble trajectory (taken at 120 ps intervals) with a backbone 
RMSD cut-off of 2.0 Å over the entire heterodimer complex identified 586 clusters. The three 
most populated clusters identified from the ensemble trajectory had a population of 24.2% 
(lincyc-c1), 20.8% (lincyc-c2) and 11.0% (lincyc-c3). The three most populated clusters are 
shown in Figure 4.2. The linear peptide in lincyc-c1, lincyc-c2 and lincyc-c3 has been 
henceforth labelled as lin-c1, lin-c2 and lin-c3 respectively. 
  
 Side view Top view 
lincyc-c1 
(24.2%) 
 
   
 
lincyc-c2 
(20.8%) 
 
 
 
    
lincyc-c3 
(11.0%) 
 
 
 
 
Figure 4.2 – Ribbon and explicit aromatic ring representations of the three most populated clusters (green – 
Tyr63; purple – Phe67). The linear peptide is shown in blue and the cyclic peptide is shown in red. 
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The linear peptide of lincyc-c1 (lin-c1) and lincyc-c3 (lin-c3) was observed to widen 
between the N- and C- termini. Lin-c1 and lin-c3 were identified to adopt a significantly 
different conformation compared to what was observed in its free and mutated states [85, 89]. 
In particular, a broader β-turn was identified to adjust for the significant widening of the 
distance between the N- and C- termini. The widening of the termini separation enables the 
linear peptide to partially engulf the cyc(60-70) peptide. The four aromatic side-chains (Tyr63 
and Phe67) of the two peptides exist on the same face of the peptide (i.e. the heterodimer 
complex exhibits distinct polar and non-polar faces), forming a distinct hydrophobic and 
hydrophilic cluster (Figure 4.3A, 4.3C), similar to what was shown in previous simulations of 
cyc(60-70) in its monomeric state (discussed in Section 3.4.2.2). In contrast, the linear peptide 
in lincyc-c2 (lin-c2) was found to dock adjacent to cyc(60-70), interacting specifically to one 
side of cyc(60-70) (Figure 4.2, blue ribbon). This formed a “loose” hydrophobic region 
(Figure 4.3B, discussed in Section 4.4.3).  
 
 
Figure 4.3 – The explicit representation of the hydrophobic residues (green) and the hydrophilic residues (purple) 
of the three most populated clusters: (A) lincyc-c1, (B) lincyc-c2 and (C) lincyc-c3. 
 
The hydrophobic β-turn region observed in the cyclic peptide consisting of residues 
Thr64, Gly65 and Ile66 was found to be similar to what was observed in Chapter 3. The 
A B C 
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cyc(60-70) peptide was identified to retain its elongated conformation, with stacking of the 
aromatic rings. Cyc(60-70) was previously characterised as flexible, exhibiting a dynamic 
hydrophobic core with a cluster population size of 13.8% (ensem-c1, Chapter 3). However as a 
linear-cyclic heterodimer complex, the major cluster of cyc(60-70) was calculated to exhibit a 
population size of 66.1% (1.3 Å cut-off). This suggests that dimerisation inhibits structural 
flexibility of cyc(60-70). Interestingly, cyc(60-70) (in a dimer complex) in the three clusters 
was identified to be similar to ensem-c1 (Chapter 3) with a backbone RMSD value of no 
higher than 0.91 Å (Figure 4.4). 
 
 
Figure 4.4 - An overlay of cyc(60-70) of lincyc-c1 (red) and ensem-c1 (blue).  
 
 The cyclic peptide was previously calculated to have an average of 4.7 H-bonds per 
analysed frame (Section 3.3.2.2). However in a dimer, the cyclic peptide was found to be 
significantly more stable, mediated by a 22% increase in intra-molecular hydrogen bonding 
(5.7 H-bonds per frame). The H-bond existence profile of the cyclic peptide (as a dimer) is 
shown in Figure 4.5. 
 Inspection of Figure 4.5 reveals significant intra-molecular H-bonds of cyc(60-70). The 
persistent H-bonds (8 identified) correspond to bonds formed between Gln70(NH)-Met60(O), 
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Thr68(NH)-Thr62(O), Ile66(NH)-Thr64(O), Thr64(NH)-Ile66(O), Thr62(NH)-Thr68(O), 
Ser61(OG,HG)-Asp69(OD1), Ser61(OG,HG)-Asp69(OD2), and Met60(NH)-Gln70(O), 
respectively. It is important to note that six of the eight identified persistent H-bonds occur 
between the backbone of the two-strands (Figure 4.6), which contributes to the structural 
stability of the cyc(60-70) structure. This suggests that bound lin(60-70) has a stabilising effect 
on the cyc(60-70) structure.  
 
Figure 4.5 – Intra-molecular H-bond existence profile of the 2.8µs simulation calculated over cyc(60-70). Red 
lines indicate H-bond existence for particular interactions labelled by index, in order of initial appearance in 
trajectory. There are eight identifiable persistent H-bonds labelled with indices 83, 133, 154, 180, 233, 251, 252 
and 276. These indices correspond to Gln70(NH)-Met60(O), Thr68(NH)-Thr62(O), Ile66(NH)-Thr64(O), 
Thr64(NH)-Ile66(O), Thr62(NH)-Thr68(O), Ser61(OG,HG)-Asp69(OD1), Ser61(OG,HG)-Asp69(OD2) and 
Met60(NH)-Gln70(O), respectively. 
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Figure 4.6 - The identified intra-molecular backbone hydrogen bonds formed in cyc(60-70). 
 
 The secondary structure evolution of the cyc(60-70) (Figure 4.7A) indicates that the 
peptide retains its characteristic strand-turn-strand motif throughout the 2.8 µs of simulation. 
The cyclic peptide was found to undergo minor structural fluctuations with the two strands 
Met60-Tyr63 and Phe67-Gln70 persistently adopting extended conformations. Section 3.3 and 
3.4 revealed that cyc(60-70) was particular flexible in the central core region. However, in a 
heterodimeric state, the central core region of the cyclic peptide is less flexible, which further 
suggests that the linear peptide has a stabilising effect on cyc(60-70). 
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Figure 4.7 - The secondary structure evolution of (A) cyc(60-70) and (B) lin(60-70) over 2.8µs of simulation. The 
secondary structure colour codes: Green – turn; Yellow – extended conformation; Gold – hydrogen bridge; White 
– coil; Blue – 3-10 helix; Red – π-helix. 
 
 Inspection of Figure 4.7B reveals the linear peptide in the dimer complex, lin(60-70), 
to possess a high degree of conformational fluctuation. Interestingly, the linear peptide was 
previously shown to be extremely stable in its isolated monomeric state [89]. However as a 
dimer, lin(60-70) was observed to be much more dynamic, adopting a wide range of structural 
conformations.  
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This indicates that whilst lin(60-70) stabilises cyc(60-70), cyc(60-70) induces a 
destabilising effect on the lin(60-70) structure (discussed in Section 4.4.2).  
Since lin(60-70) is extremely flexible and dynamic, it can be hypothesised that the 
cyclic-induced lin(60-70)’s increased flexibility makes it difficult/prevents the peptides 
interacting with other like-peptides. This hypothesis is similar to the mechanism of fibril 
inhibition by oxidised-Met(60-70) due to the increased flexibility and dynamics of the peptide 
proposed in [85].  
 
4.4.2 Lin(60-70) is more dynamic in the presence of cyc(60-70) 
To further characterise the dynamics of lin(60-70), the H-bond profile of lin(60-70) was 
calculated (Figure 4.8). Inspection of Figure 4.8 reveals a lack of persistent H-bonds except for 
the simulation time period approximately between 1.5 µs to 1.8 µs and 2.2 µs to 2.5 µs, 
corresponding to lincyc-c2 type structures (Figure 4.2, blue ribbon). The linear peptide in this 
cluster adopts a β-hairpin conformation similar to those observed in our previous MD studies 
[84, 85, 89] stabilised by intra-molecular hydrogen bonding. The persistent H-bond during this 
simulation time period was identified to correspond to Asp69(NH)-Ser61(OG), Thr68(NH)-
Met60(O), Thr68(NH)-Ser61(OG), Ile66(NH)-Thr62(OG1), Gly65(NH)-Thr62(O), 
Thr62(NH)-Ile66(O), Ser61(OG,HG)-Asp69(OD2) and Ser61(OG,HG)-Asp69(O), 
respectively. Thr68(NH)-Met60(O), Gly65(NH)-Thr62(O) and Thr62(NH)-Ile66(O) were 
identified to be H-bonds between the linear peptide backbone, indicating structural stability. 
This is a significant observation because the lack of these backbone H-bonds enables the linear 
peptide to adopt a wider range of conformations, promoting conformations similar to those 
observed in lin-c1 and lin-c3. The linear peptides in these two clusters were found to engulf 
cyc(60-70), which promotes the formation of a large contiguous hydrophobic region. This 
suggests that the linear peptide that possess backbone H-bonds i.e. a conformation where lin 
(60-70) “docks” adjacent to cyc(60-70), exhibits substantially different dynamics than the 
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conformations observed in lin-c1, lin-c3 and a majority of the simulation trajectory. 
Furthermore, the linear peptide (in a heterodimer complex with cyc(60-70)) was calculated to 
exhibit an average of 2.8 H-bonds per analysed frame, significantly lower than the calculated 
average H-bonds identified in lin(60-70) in its simulated monomeric state (4.2 H-bonds per 
frame).  
 
Figure 4.8 – Intra-molecular H-bond existence profile of the 2.8µs simulation calculated over lin(60-70). Red 
lines indicate H-bond existence for particular interactions labelled by index, in order of initial appearance in 
trajectory. There are eight identifiable persistent H-bonds in the highlighted region with indices 108, 145, 147, 
175, 190, 281, 305 and 306. These indices correspond to Asp69(NH)-Ser61(OG), Thr68(NH)-Met60(O), 
Thr68(NH)-Ser61(OG), Ile66(NH)-Thr62(OG1), Gly65(NH)-Thr62(O), Thr62(NH)-Ile66(O), Ser61(OG,HG)-
Asp69(OD2) and Ser61(OG,HG)-Asp69(O), respectively. The highlighted simulated time period corresponds to 
β-hairpin like conformations that lin(60-70) adopts (lin-c2). The substantial increase in H-bonds during this time 
period suggests that lin(60-70) cannot adopt similar conformations like those observed in lin-c1 and lin-c3.  
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Another quantitative analysis to characterise the overall peptide structure of lin(60-70) 
involves measuring the distance between the N- and C- termini (peptide extension) and its 
sphericity (radius of gyration, Rg). A plot of the peptide extension with respect to Rg is shown 
in Figure 4.9, which indicates the overall fold of lin(60-70) in the presence of cyc(60-70). 
 
 
Figure 4.9 - End-to-end distance with respect to the radius of gyration of the linear peptide in its monomeric state 
(red data points [89]) and as a dimer (blue data points). Ribbon representations of the peptides corresponding to 
the indicated regions of sampled conformational space are inset.  
 
 Inspection of Figure 4.9 reveals four clusters of data points. The red cluster of data 
points indicates lin(60-70) frequently samples the conformational basin at distance = 0.45 and 
Rg = 0.55nm (simplified to (0.45, 0.55)) in its monomeric state. In this basin, the peptide 
adopts a β-hairpin structure with the aromatic side chains facing one side of the peptide, 
forming a hydrophobic region. In its isolated monomeric state, the peptide is generally 
regarded as well behaved with low conformational drift. 
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Interestingly, the presence of cyc(60-70) renders lin(60-70) more dynamic. In the 
presence of cyc(60-70), lin(60-70) frequently samples three conformation basins at (0.30, 
0.60), (0.75, 0.63) and (1.00, 0.73), each with distinct differences (as evident of the tight 
cluster in data points). This suggests the peptide is able to adopt a wide range of 
conformations. It is important to note that the aromatic residues all face one side of the 
peptide, promoting the formation of a large hydrophobic face (discussed in Section 4.4.3). 
These observations suggest that cyc(60-70) induces a destabilising effect on lin(60-70), 
rendering it too dynamic to adopt a fibril favouring conformation and therefore slowing 
down/reducing the likelihood of the initiation of the aggregation process. 
 
4.4.3 Lincyc(60-70) exhibits propensity to form hydrophilic/hydrophobic faces 
The importance of hydrophobic interactions, especially those between aromatic side chains, 
was discussed in Section 3.4.2.2. They have been shown to play an important role in the 
stability [198, 199] and formation of amyloid fibrils [201, 202]. These findings suggest that 
the two aromatic rings (Tyr63 and Phe67) may participate/facilitate aggregation. Additionally, 
previous MD studies have shown distinct differences in aromatic side-chain orientations 
between fibril forming and fibril inhibiting conditions [85, 89]. 
 A previous study has identified that under fibril-inhibiting conditions, the aromatic 
rings adopt conformations where Tyr63 and Phe67 lie on the same side, whereas structures 
obtained under fibril-favouring conditions favour aromatic rings on opposing sides of the 
peptide [89]. Quantifying the relative orientations between Thy63 and Phe67 is therefore 
important. This was quantified by calculating the average angle between the Cα-Cγ vector of 
Tyr63 and the Cα-Cγ vector of Phe67. Angles that were calculated to be less than 90° indicate 
that the aromatic rings lie on the same side whilst angles greater than 90° indicate that the 
rings lie on opposing sides of the peptide. In Section 3.4.2.2, cyc(60-70) was identified as 
being extremely flexible, able to display both fibril-inhibiting and fibril-favouring 
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characteristics. It was hypothesised that in the presence of lin(60-70), the dynamics of the 
aromatic rings will greatly favour fibril-inhibiting characteristics i.e. angles less than 90°. The 
histogram and representative structures obtained from the 2.8 µs ensemble simulation is 
presented in Figure 4.10. 
Figure 4.10 reveals that cyc(60-70) now greatly favours structures with a relative 
aromatic ring orientation of less than 90° (peak at 54°) as postulated in Section 3.4.2.2. This 
suggests cyc(60-70) now exhibits fibril-favouring characteristics, unlike what was initially 
observed in its monomer state (Figure 3.11).  Additionally, the relative ring orientation for 
lin(60-70) over the 2.8 µs ensemble trajectory also resembles that observed under fibril-
inhibiting conditions. Two peaks were observed for lin(60-70) at 27° and 90° with both 
representative structures similar to what was observed in the (1.00, 0.73) basin in the peptide 
extension with respect to the radius of gyration plot in Figure 4.9. This suggests that a 
widening of the β-hairpin and, more significantly, the increase in separation between the N- 
and C- termini, exhibit fibril-inhibiting characteristics and are favourable conformations. The 
total percentage of structures that were within 0° to 90° for cyc(60-70) and lin(60-70) was 
calculated to be 83% and 62%, respectively. These observations can be explained by 
postulating that both lin(60-70) and cyc(60-70) exhibit a propensity to form a strong 
hydrophobic face. This subsequently reorientates the aromatic rings towards these large 
contiguous regions, resulting in relative ring orientations that are less than 90°. The aromatic 
stacking inside the hydrophobic area in both peptides suggests it does not allow for the 
hydrophobic regions to be exposed for interaction with other like-peptides.  
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Figure 4.10 – A histogram of the Tyr63 and Phe67 relative aromatic ring orientation (X-axis) obtained from the 
2.8 µs lincyc(60-70) ensemble trajectory. The percentage of structures (Y-axis) with respect to their angles (X-
axis) is shown. A total of forty-one bins were used over the range 0 – 180°, with each data point corresponding to 
an angle interval of 4.5°. Angle < 90° indicates both rings are on one side of the peptide, while > 90° indicates 
rings exist on opposite sides. Structures illustrating the relative ring orientations of cyc(60-70) (red) and lin(60-
70) (blue) are represented in insets. 
 
4.4.4 Proposed mechanism of fibril inhibition by cyc(60-70) 
As discussed in Chapter 3, structural flexibility and elongation bias are major characteristics of 
cyc(60-70). The structural flexibility of cyc(60-70) enables the peptide to adopt a favourable 
conformation that may mediate the binding interactions with lin(60-70), rendering the linear 
peptides unable to self-associate. Additionally, the cyclic peptide favoured elongated 
conformations that may possibly maximise hydrophobic interactions that subsequently abolish 
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fibril formation by “capping” the fibril seed. This generates a hydrophilic “shell” that 
discourages further peptides self-association (Figure 4.11) similar to the capping effects of 
lipids shown previously [89, 90, 146, 147]. The scrambled structure of apoC-II(60-70) which 
was revealed to exhibit no inhibition activity, was identified to be more compact and spherical 
with reduced flexibility and a significantly more “loose” hydrophobic region (Section 3.4.2.4). 
These observations further indicate the importance of a “dense” hydrophobic region as well as 
the peptide’s ability to adopt a wide range of possible conformations to adhere to and “cap” 
the fibrillogenic apoC-II(60-70) peptide. 
Results in Chapter 4 have identified that the cyc(60-70) structure is stabilised by the 
interactions with lin(60-70), supporting the idea of the capping model proposed. Interestingly, 
cyc(60-70) induced increased flexibility in lin(60-70), suggesting that lin(60-70) can no longer 
adopt a stable fibril favouring conformation to initiate or promote the fibril forming process. 
Additionally, cyc(60-70) was identified to a form large, contiguous hydrophobic region 
capable to attract and maximise hydrophobic contacts with the fibrillogenic apoC-II(60-70) 
peptide and expose the other hydrophilic face, that prevents adherence of like-peptides. 
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Figure 4.11 – A two-dimensional schematic representation of the proposed mechanism by which cyc(60-70) 
(blue) inhibits fibril formation by apoC-II(60-70) (green). The hydrophobic residues (excluding Met60 for 
simplification) in the central core region (red) form a large contiguous hydrophobic region (pink) and prevent 
apoC-II(60-70) from interacting with other fibrillogenic apoC-II(60-70) peptides, abolishing the fibril formation 
process. 
 
4.5 Conclusions 
 
In this section, we have investigated the structure and dynamics of a cyclic peptide, cyc(60-
70), derived from an amyloidogenic sequence within apoC-II. Experimental data has shown 
cyc(60-70) as an effective inhibitor of fibril formation by apoC-II(60-70) [88]. Understanding 
the mechanisms by which the molecules block formation of amyloid fibrils can provide insight 
into the processes leading to fibril aggregation. This subsequently may lead to the design of 
therapeutic agents to prevent amyloidosis. 
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Inhibition of fibril formation by cyc(60-70) can be postulated to occur via a number of 
processes: (i) cyc(60-70) sequesters soluble fibrillogenic peptide through strong binding, (ii) 
transient interaction of cyc(60-70) with soluble fibrillogenic peptide reduces its ability to form 
fibrils by subtly shifting its dynamic structure equilibrium, or (iii) cyc(60-70) binds to small 
oligomeric aggregates of the fibrillogenic peptides. Given the substoichiometric nature of 
cyc(60-70) activity, processes 2 or 3 would appear more likely [88].  
The presence of a hydrophobic face identified in cyc(60-70) in numerous simulations 
suggests that hydrophobic interactions are a key feature to its mechanism of action. By 
mediating binding interactions with lin(60-70), the peptide becomes unable to self-associate. 
Therefore, a “capping” model for cyc(60-70) is proposed as the major mechanism of fibril 
inhibitive action by apoC-II(60-70). This mechanism is facilitated by the flexible and 
elongated structure of cyc(60-70). Furthermore, the peptide preferentially exhibits distinct 
hydrophobic and hydrophilic surface, which enables the peptide to maximise hydrophobic 
contacts with the fibrillogenic peptide. This can effectively create a cap around the fibril seed, 
generating an outer hydrophilic space that discourages further peptide self-association in 
accord with the capping effects of lipids shown previously [89, 90, 146, 147].  
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5. Summary and future directions 
 
In Chapter 3, we have described the characterisation of the structure and dynamics of the 
cyclic derivative (cyc(60-70)) of human apolipoprotein C-II(60-70) (apoC-II(60-70)). The 
isolated apoC-II(60-70) cyclic peptide (cyc(60-70)) was found to be extremely flexible in the 
central core region with a characteristic strand-turn-strand motif and an elongation bias, 
forming a distinct hydrophilic region and a “tight” hydrophobic region. These features were 
found to be consistent with the NMR obtained structures, which suggests that they are the 
defining characteristics of cyc(60-70). Conversely, the scrambled sequence of the cyclic apoC-
II(60-70) peptide (scram(60-70)) was found to be spherical in shape with a more scattered 
hydrophobic region and reduced flexibility (discussed in Section 3.4.2.4).  
In Chapter 4, we investigated how this cyclic peptide interacts with the linear apoC-
II(60-70) peptide. Cyc(60-70) was found to be substantially stabilised by inter-molecular 
hydrogen bonds in the presence of its linear analog. Surprisingly, the linear apoC-II(60-70) 
peptide was found to be more dynamic in the presence of cyc(60-70) i.e. conservation of 
conformational entropy, where the flexibility of cyc(60-70) was transferred to the linear 
peptide. Based on these findings, we proposed a capping mechanism by which cyc(60-70) 
inhibits fibril formation by apoC-II(60-70). The structural flexibility of cyc(60-70) enables the 
peptide to possibly maximise hydrophobic interactions that subsequently abolish fibril 
formation by “capping” the fibril seed, generating a hydrophilic “shell” that discourages 
further peptides from self-associating (discussed in Section 4.4.4).  
We are currently performing ongoing simulation studies of more complex systems 
involving interactions between cyclic peptides and amyloid peptide oligomers which will 
provide further insights into the amyloid fibril inhibition process. Studying the influences of 
cyclic peptides on oligomeric complexes brings us further towards a full understanding of the 
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(possibly multiple) mechanisms by which the cyclic analog inhibits fibril formation, as well as 
possible fibril dissolution. We briefly discuss the preliminary results acquired thus far. 
The current ongoing work involves molecular dynamic (MD) simulations of two cyclic 
peptides placed in a simulation box size of 70 Å x 70 Å x 70 Å with a stable tetramer β-sheet 
of apoC-II(60-70) [85] aligned in an anti-parallel orientation (Figure 5.1). The aim is to 
investigate the effects that cyc(60-70) has on the stable fibril seed. Preliminary results indicate 
that the oligomer forms a cluster composed of aromatic rings in the presence of two cyclic 
apoC-II(60-70) peptides (Figure 5.2). Furthermore, the tetramer has been observed to be more 
dynamic overall, especially the outer-most apoC-II(60-70) strands. This suggests that cyc(60-
70) has a significant effect on the stability and dynamics on the apoC-II(60-70) fibril seed. 
Although observations indicate promising results, further simulation and analysis is required. 
 
 
Figure 5.1 - Structural representation of the initial arrangement of the tetrameric fibrils seed of apoC-II(60-70) 
with cyc(60-70) on either side of the oligomer. 
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Figure 5.2 - Structural representation of the last frame of the simulation (~150ns). The aromatic rings (yellow) are 
observed to form a large hydrophobic region with the cyclic peptide (grey). 
 
An extension of the work discussed in this thesis will involve performing MD 
simulations of the full-length apoC-II protein in the presence of cyc(60-70). This will provide 
a way to systematically test the robustness of the proposed “capping” model that cyc(60-70) 
adopts (Section 4.4.4). These findings can then be compared and analysed against the full 
length apoC-II obtained through experimental and theoretical studies [135]. In addition to 
examining this proposed model, further insight towards fibril formation by apoC-II and fibril 
inhibition by cyc(60-70) will provide a crucial step in treating amyloidosis.  
Additional studies may involve the simulation of multiple cyclic apoC-II(60-70) 
peptides in the presence of multiple apoC-II(60-70) peptides to determine whether cyc(60-70) 
or apoC-II(60-70) self-aggregate in the presence of each other. This will provide crucial 
information regarding the feasibility of utilising cyc(60-70) as an effective inhibitor of fibril 
formation by apoC-II(60-70).  
From then on, cyc(60-70) could be simulated with other fibrillogenic peptides. It may 
be very well possible that cyc(60-70) could also exhibit therapeutic potential to prevent or 
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reverse fibril formation by other peptides such as hiAPP. The results could also provide insight 
towards cyc(60-70) having no inhibitory effect on Aβ(1-40) [88]. Regardless, additional 
experimental and theoretical studies involving cyc(60-70) will aid in the design of potential 
cyclic peptides with optimised fibril inhibitory efficacy. 
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